{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/dscott-tantustech/ab_test_guide_in_python/blob/master/Sprint_26_V2__Text_Ingest_1900pp_pdf.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 73
        },
        "id": "9ChoCKWHyUaR",
        "outputId": "d2b47b8b-2d15-4507-ec89-4eb3b3ef0e80"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "\n",
              "     <input type=\"file\" id=\"files-71facd8f-a083-4ad5-9221-4af1d6542e7d\" name=\"files[]\" multiple disabled\n",
              "        style=\"border:none\" />\n",
              "     <output id=\"result-71facd8f-a083-4ad5-9221-4af1d6542e7d\">\n",
              "      Upload widget is only available when the cell has been executed in the\n",
              "      current browser session. Please rerun this cell to enable.\n",
              "      </output>\n",
              "      <script>// Copyright 2017 Google LLC\n",
              "//\n",
              "// Licensed under the Apache License, Version 2.0 (the \"License\");\n",
              "// you may not use this file except in compliance with the License.\n",
              "// You may obtain a copy of the License at\n",
              "//\n",
              "//      http://www.apache.org/licenses/LICENSE-2.0\n",
              "//\n",
              "// Unless required by applicable law or agreed to in writing, software\n",
              "// distributed under the License is distributed on an \"AS IS\" BASIS,\n",
              "// WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\n",
              "// See the License for the specific language governing permissions and\n",
              "// limitations under the License.\n",
              "\n",
              "/**\n",
              " * @fileoverview Helpers for google.colab Python module.\n",
              " */\n",
              "(function(scope) {\n",
              "function span(text, styleAttributes = {}) {\n",
              "  const element = document.createElement('span');\n",
              "  element.textContent = text;\n",
              "  for (const key of Object.keys(styleAttributes)) {\n",
              "    element.style[key] = styleAttributes[key];\n",
              "  }\n",
              "  return element;\n",
              "}\n",
              "\n",
              "// Max number of bytes which will be uploaded at a time.\n",
              "const MAX_PAYLOAD_SIZE = 100 * 1024;\n",
              "\n",
              "function _uploadFiles(inputId, outputId) {\n",
              "  const steps = uploadFilesStep(inputId, outputId);\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  // Cache steps on the outputElement to make it available for the next call\n",
              "  // to uploadFilesContinue from Python.\n",
              "  outputElement.steps = steps;\n",
              "\n",
              "  return _uploadFilesContinue(outputId);\n",
              "}\n",
              "\n",
              "// This is roughly an async generator (not supported in the browser yet),\n",
              "// where there are multiple asynchronous steps and the Python side is going\n",
              "// to poll for completion of each step.\n",
              "// This uses a Promise to block the python side on completion of each step,\n",
              "// then passes the result of the previous step as the input to the next step.\n",
              "function _uploadFilesContinue(outputId) {\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  const steps = outputElement.steps;\n",
              "\n",
              "  const next = steps.next(outputElement.lastPromiseValue);\n",
              "  return Promise.resolve(next.value.promise).then((value) => {\n",
              "    // Cache the last promise value to make it available to the next\n",
              "    // step of the generator.\n",
              "    outputElement.lastPromiseValue = value;\n",
              "    return next.value.response;\n",
              "  });\n",
              "}\n",
              "\n",
              "/**\n",
              " * Generator function which is called between each async step of the upload\n",
              " * process.\n",
              " * @param {string} inputId Element ID of the input file picker element.\n",
              " * @param {string} outputId Element ID of the output display.\n",
              " * @return {!Iterable<!Object>} Iterable of next steps.\n",
              " */\n",
              "function* uploadFilesStep(inputId, outputId) {\n",
              "  const inputElement = document.getElementById(inputId);\n",
              "  inputElement.disabled = false;\n",
              "\n",
              "  const outputElement = document.getElementById(outputId);\n",
              "  outputElement.innerHTML = '';\n",
              "\n",
              "  const pickedPromise = new Promise((resolve) => {\n",
              "    inputElement.addEventListener('change', (e) => {\n",
              "      resolve(e.target.files);\n",
              "    });\n",
              "  });\n",
              "\n",
              "  const cancel = document.createElement('button');\n",
              "  inputElement.parentElement.appendChild(cancel);\n",
              "  cancel.textContent = 'Cancel upload';\n",
              "  const cancelPromise = new Promise((resolve) => {\n",
              "    cancel.onclick = () => {\n",
              "      resolve(null);\n",
              "    };\n",
              "  });\n",
              "\n",
              "  // Wait for the user to pick the files.\n",
              "  const files = yield {\n",
              "    promise: Promise.race([pickedPromise, cancelPromise]),\n",
              "    response: {\n",
              "      action: 'starting',\n",
              "    }\n",
              "  };\n",
              "\n",
              "  cancel.remove();\n",
              "\n",
              "  // Disable the input element since further picks are not allowed.\n",
              "  inputElement.disabled = true;\n",
              "\n",
              "  if (!files) {\n",
              "    return {\n",
              "      response: {\n",
              "        action: 'complete',\n",
              "      }\n",
              "    };\n",
              "  }\n",
              "\n",
              "  for (const file of files) {\n",
              "    const li = document.createElement('li');\n",
              "    li.append(span(file.name, {fontWeight: 'bold'}));\n",
              "    li.append(span(\n",
              "        `(${file.type || 'n/a'}) - ${file.size} bytes, ` +\n",
              "        `last modified: ${\n",
              "            file.lastModifiedDate ? file.lastModifiedDate.toLocaleDateString() :\n",
              "                                    'n/a'} - `));\n",
              "    const percent = span('0% done');\n",
              "    li.appendChild(percent);\n",
              "\n",
              "    outputElement.appendChild(li);\n",
              "\n",
              "    const fileDataPromise = new Promise((resolve) => {\n",
              "      const reader = new FileReader();\n",
              "      reader.onload = (e) => {\n",
              "        resolve(e.target.result);\n",
              "      };\n",
              "      reader.readAsArrayBuffer(file);\n",
              "    });\n",
              "    // Wait for the data to be ready.\n",
              "    let fileData = yield {\n",
              "      promise: fileDataPromise,\n",
              "      response: {\n",
              "        action: 'continue',\n",
              "      }\n",
              "    };\n",
              "\n",
              "    // Use a chunked sending to avoid message size limits. See b/62115660.\n",
              "    let position = 0;\n",
              "    do {\n",
              "      const length = Math.min(fileData.byteLength - position, MAX_PAYLOAD_SIZE);\n",
              "      const chunk = new Uint8Array(fileData, position, length);\n",
              "      position += length;\n",
              "\n",
              "      const base64 = btoa(String.fromCharCode.apply(null, chunk));\n",
              "      yield {\n",
              "        response: {\n",
              "          action: 'append',\n",
              "          file: file.name,\n",
              "          data: base64,\n",
              "        },\n",
              "      };\n",
              "\n",
              "      let percentDone = fileData.byteLength === 0 ?\n",
              "          100 :\n",
              "          Math.round((position / fileData.byteLength) * 100);\n",
              "      percent.textContent = `${percentDone}% done`;\n",
              "\n",
              "    } while (position < fileData.byteLength);\n",
              "  }\n",
              "\n",
              "  // All done.\n",
              "  yield {\n",
              "    response: {\n",
              "      action: 'complete',\n",
              "    }\n",
              "  };\n",
              "}\n",
              "\n",
              "scope.google = scope.google || {};\n",
              "scope.google.colab = scope.google.colab || {};\n",
              "scope.google.colab._files = {\n",
              "  _uploadFiles,\n",
              "  _uploadFilesContinue,\n",
              "};\n",
              "})(self);\n",
              "</script> "
            ],
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Saving embeddings.pkl to embeddings (1).pkl\n"
          ]
        }
      ],
      "source": [
        "# MODULE 0: File Uploads\n",
        "# An interactive menu will pop up to choose the files.\n",
        "# 2 Files to upload:\n",
        "#                   1.'Reference_Workbook_CY_Provisions_CY2024_DRS_Topics_Subtopics.xlsx'\n",
        "#                   2.'CMS-2023-0121-0001_content_1920pp.pdf'\n",
        "#                   3.(After Module 5 is run once) embeddings.pkl\n",
        "\n",
        "from google.colab import files\n",
        "uploaded = files.upload()\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "y1g2vLxFhta9",
        "outputId": "bcd68c98-cd1f-45fc-eef6-eb59d8666bfa"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Index(['Topic', 'Subtopic', 'Topic-Subtopic', 'Start_Page', 'End Page',\n",
            "       'InsightsAI_Topic', 'InsightsAI_Subtopic', 'InsightsAI_TopicSubtopic',\n",
            "       'Keywords'],\n",
            "      dtype='object')\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "<ipython-input-3-5f747da95169>:9: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  Topic_only_df.drop(columns=['Topic','Subtopic', 'Topic-Subtopic','InsightsAI_Subtopic','InsightsAI_TopicSubtopic'], inplace=True)\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"Topic_only_df\",\n  \"rows\": 33,\n  \"fields\": [\n    {\n      \"column\": \"Start_Page\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 357,\n        \"min\": 12,\n        \"max\": 1296,\n        \"num_unique_values\": 33,\n        \"samples\": [\n          1220,\n          441,\n          835\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"End Page\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 351,\n        \"min\": 48,\n        \"max\": 1299,\n        \"num_unique_values\": 33,\n        \"samples\": [\n          1295,\n          447,\n          848\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"InsightsAI_Topic\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 33,\n        \"samples\": [\n          \"7E_Other Provisions in the Regulation\",\n          \"3F_OUD OTP Coverage\",\n          \"3Q_Changes to the Basic Health Program Regulations\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Keywords\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 27,\n        \"samples\": [\n          \"Rural Health Clinic Services Act of 1977\\nCAA 2023\\nNurse Practitioner (NP)\\nMarriage and Family Therapist (MFT)\\nMental Health Counselor (MHC)\\n491.2\\n491.8\\nRural Health Clinics (RHC)\\nFederally Qualified Health Center (FQHC)\\nCertification of Coverage (CfC)\\nshortage areas\\nOmnibus Budget Reconciliation Act of 1990 (OBRA)\\nConsensus Model\\nprimary care\",\n          \"Medicare Part B\\nPreventive vaccines\\nPneumococcal\\nInfluenza\\nHepatitis B\\nCOVID-19 vaccines\\nHigh-risk individuals\\nCoinsurance\\nAnnual Part B deductible\\nAverage Wholesale Price (AWP)\\nReasonable cost\\nMedicare Part D\\nZoster vaccine\\nPublic awareness campaign\\nHealth coverage proposal\",\n          \"Clinical diagnostic laboratory tests\\nCDLT\\nLaboratory tests\\nProtecting Medicare and American Farmers from Sequester Cuts Act\\nPMAFSCA\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "Topic_only_df"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-b6afbed2-4705-428c-85b3-982b1b462593\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Start_Page</th>\n",
              "      <th>End Page</th>\n",
              "      <th>InsightsAI_Topic</th>\n",
              "      <th>Keywords</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>12</td>\n",
              "      <td>48</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "      <td>1848(c)(1)(B)\\nIndirect Cost PE RVU\\nIndirect ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>49</td>\n",
              "      <td>67</td>\n",
              "      <td>2C_Potentially Misvalued Services</td>\n",
              "      <td>Potentially misvalued codes\\npotentially misva...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>68</td>\n",
              "      <td>129</td>\n",
              "      <td>2D_Telehealth Services</td>\n",
              "      <td>Category 1\\nCategory 2\\nCategory 3\\ntemporary\\...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>19</th>\n",
              "      <td>130</td>\n",
              "      <td>239</td>\n",
              "      <td>2E_Valuation of Specific Codes</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>48</th>\n",
              "      <td>240</td>\n",
              "      <td>256</td>\n",
              "      <td>2F_E&amp;M Visits</td>\n",
              "      <td>Evaluation and Management (E/M) Visits\\nE/M vi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>51</th>\n",
              "      <td>257</td>\n",
              "      <td>260</td>\n",
              "      <td>2G_Geographic Practice Cost Indices</td>\n",
              "      <td>Geographic practice cost indices\\nGPCIs\\nWork ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>54</th>\n",
              "      <td>261</td>\n",
              "      <td>264</td>\n",
              "      <td>2H_Payment for Skin Substitutes</td>\n",
              "      <td>Skin substitutes\\nSynthetic skin</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>57</th>\n",
              "      <td>265</td>\n",
              "      <td>276</td>\n",
              "      <td>2I_Supervision of OP Therapy Svcs, KX Modifier...</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>63</th>\n",
              "      <td>277</td>\n",
              "      <td>307</td>\n",
              "      <td>2J_Advancing Access to Behavioral Health Services</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>71</th>\n",
              "      <td>308</td>\n",
              "      <td>350</td>\n",
              "      <td>2K_Medicare Parts A and B Payment for Dental S...</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>78</th>\n",
              "      <td>351</td>\n",
              "      <td>385</td>\n",
              "      <td>3A_Drugs and Biological Products Paid Under Pa...</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>85</th>\n",
              "      <td>386</td>\n",
              "      <td>420</td>\n",
              "      <td>3B_RHCs and FQHCs</td>\n",
              "      <td>Rural Health Clinics (RHCs)\\nFederally Qualifi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>97</th>\n",
              "      <td>421</td>\n",
              "      <td>428</td>\n",
              "      <td>3C_RHCs and FQHCs Conditions for Certification...</td>\n",
              "      <td>Rural Health Clinic Services Act of 1977\\nCAA ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>98</th>\n",
              "      <td>429</td>\n",
              "      <td>437</td>\n",
              "      <td>3D_Clinical Lab Fee Schedule</td>\n",
              "      <td>Clinical diagnostic laboratory tests\\nCDLT\\nLa...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>101</th>\n",
              "      <td>438</td>\n",
              "      <td>440</td>\n",
              "      <td>3E_Pulm/Cardiac/Intensive Cardiac Rehab Expans...</td>\n",
              "      <td>Pulmonary rehabilitation\\nCardiac rehabilitati...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>102</th>\n",
              "      <td>441</td>\n",
              "      <td>447</td>\n",
              "      <td>3F_OUD OTP Coverage</td>\n",
              "      <td>Section 2005\\nSUPPORT Act\\nOUD (opioid use dis...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>105</th>\n",
              "      <td>448</td>\n",
              "      <td>686</td>\n",
              "      <td>3G_MSSP</td>\n",
              "      <td>MSSP\\nShared savings \\nACO(s)\\naccountable car...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>106</th>\n",
              "      <td>687</td>\n",
              "      <td>700</td>\n",
              "      <td>3H_Part B Payment Preventive Vaccine</td>\n",
              "      <td>Medicare Part B\\nPreventive vaccines\\nPneumoco...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>110</th>\n",
              "      <td>701</td>\n",
              "      <td>725</td>\n",
              "      <td>3I_MDPP</td>\n",
              "      <td>Medicare Diabetes Prevention Program\\nMDPP\\nMD...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>111</th>\n",
              "      <td>726</td>\n",
              "      <td>744</td>\n",
              "      <td>3J_Appropriate Use Criteria for Advanced Diagn...</td>\n",
              "      <td>Appropriate use criteria\\nAUC\\nClinical decisi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>112</th>\n",
              "      <td>745</td>\n",
              "      <td>785</td>\n",
              "      <td>3K_Medicaid Provider Enrollment</td>\n",
              "      <td>Provider, Enrollment, Chain and Ownership Syst...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>113</th>\n",
              "      <td>786</td>\n",
              "      <td>798</td>\n",
              "      <td>3L_Expand Diabetes Screening and Diabetes Defi...</td>\n",
              "      <td>HbA1c\\nA1c\\nDefinition of diabetes \\nHemoglobi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>114</th>\n",
              "      <td>799</td>\n",
              "      <td>813</td>\n",
              "      <td>3M_EPCS Part D</td>\n",
              "      <td>SUPPORT Act\\nCMS EPCS Program\\nPrescription Dr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>115</th>\n",
              "      <td>814</td>\n",
              "      <td>823</td>\n",
              "      <td>3N_Ambulance Fee and GADCS</td>\n",
              "      <td>ambulance services\\nambulance fee schedule (AF...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>116</th>\n",
              "      <td>824</td>\n",
              "      <td>827</td>\n",
              "      <td>3O_Hospice: Changes to Conditions of Participa...</td>\n",
              "      <td>TEFRA\\n1861(dd)\\nconditions of participation (...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>117</th>\n",
              "      <td>828</td>\n",
              "      <td>834</td>\n",
              "      <td>3P_Solicitation: Histopathology, Cytology, and...</td>\n",
              "      <td>CLIA of 1988\\nHistopathology\\nIHC staining\\nH&amp;...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>118</th>\n",
              "      <td>835</td>\n",
              "      <td>848</td>\n",
              "      <td>3Q_Changes to the Basic Health Program Regulat...</td>\n",
              "      <td>Immigration status\\npremium tac credit\\nCost-s...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>119</th>\n",
              "      <td>849</td>\n",
              "      <td>855</td>\n",
              "      <td>3R_Updates to the Definitions of CEHRT</td>\n",
              "      <td>Health IT certification\\nIT\\nMedicaid\\nOffice ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>120</th>\n",
              "      <td>856</td>\n",
              "      <td>868</td>\n",
              "      <td>3S_SDOH Risk Assessment in the AWV</td>\n",
              "      <td>Annual Wellness Visit\\nAWV\\nSocial Determinant...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>121</th>\n",
              "      <td>1176</td>\n",
              "      <td>1189</td>\n",
              "      <td>7_Regulatory Impact Analysis</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>126</th>\n",
              "      <td>1219</td>\n",
              "      <td>1219</td>\n",
              "      <td>7D_Changes Related to Telehealth Services</td>\n",
              "      <td>POS 10\\nnon-facility rate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>127</th>\n",
              "      <td>1220</td>\n",
              "      <td>1295</td>\n",
              "      <td>7E_Other Provisions in the Regulation</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>131</th>\n",
              "      <td>1296</td>\n",
              "      <td>1299</td>\n",
              "      <td>7F_Alternatives Considered</td>\n",
              "      <td>no alternatives were considered</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-b6afbed2-4705-428c-85b3-982b1b462593')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-b6afbed2-4705-428c-85b3-982b1b462593 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-b6afbed2-4705-428c-85b3-982b1b462593');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-093758a4-0c3f-42ce-8b27-a6af8e5af7fc\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-093758a4-0c3f-42ce-8b27-a6af8e5af7fc')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-093758a4-0c3f-42ce-8b27-a6af8e5af7fc button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_22c99c22-b55d-45fa-adce-d864b93c2ce5\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('Topic_only_df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_22c99c22-b55d-45fa-adce-d864b93c2ce5 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('Topic_only_df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "     Start_Page  End Page                                   InsightsAI_Topic  \\\n",
              "0            12        48          2B_Determination of Practice Expense RVUs   \n",
              "4            49        67                  2C_Potentially Misvalued Services   \n",
              "5            68       129                             2D_Telehealth Services   \n",
              "19          130       239                     2E_Valuation of Specific Codes   \n",
              "48          240       256                                      2F_E&M Visits   \n",
              "51          257       260                2G_Geographic Practice Cost Indices   \n",
              "54          261       264                    2H_Payment for Skin Substitutes   \n",
              "57          265       276  2I_Supervision of OP Therapy Svcs, KX Modifier...   \n",
              "63          277       307  2J_Advancing Access to Behavioral Health Services   \n",
              "71          308       350  2K_Medicare Parts A and B Payment for Dental S...   \n",
              "78          351       385  3A_Drugs and Biological Products Paid Under Pa...   \n",
              "85          386       420                                  3B_RHCs and FQHCs   \n",
              "97          421       428  3C_RHCs and FQHCs Conditions for Certification...   \n",
              "98          429       437                       3D_Clinical Lab Fee Schedule   \n",
              "101         438       440  3E_Pulm/Cardiac/Intensive Cardiac Rehab Expans...   \n",
              "102         441       447                                3F_OUD OTP Coverage   \n",
              "105         448       686                                            3G_MSSP   \n",
              "106         687       700               3H_Part B Payment Preventive Vaccine   \n",
              "110         701       725                                            3I_MDPP   \n",
              "111         726       744  3J_Appropriate Use Criteria for Advanced Diagn...   \n",
              "112         745       785                    3K_Medicaid Provider Enrollment   \n",
              "113         786       798  3L_Expand Diabetes Screening and Diabetes Defi...   \n",
              "114         799       813                                     3M_EPCS Part D   \n",
              "115         814       823                         3N_Ambulance Fee and GADCS   \n",
              "116         824       827  3O_Hospice: Changes to Conditions of Participa...   \n",
              "117         828       834  3P_Solicitation: Histopathology, Cytology, and...   \n",
              "118         835       848  3Q_Changes to the Basic Health Program Regulat...   \n",
              "119         849       855             3R_Updates to the Definitions of CEHRT   \n",
              "120         856       868                 3S_SDOH Risk Assessment in the AWV   \n",
              "121        1176      1189                       7_Regulatory Impact Analysis   \n",
              "126        1219      1219          7D_Changes Related to Telehealth Services   \n",
              "127        1220      1295              7E_Other Provisions in the Regulation   \n",
              "131        1296      1299                         7F_Alternatives Considered   \n",
              "\n",
              "                                              Keywords  \n",
              "0    1848(c)(1)(B)\\nIndirect Cost PE RVU\\nIndirect ...  \n",
              "4    Potentially misvalued codes\\npotentially misva...  \n",
              "5    Category 1\\nCategory 2\\nCategory 3\\ntemporary\\...  \n",
              "19                                                      \n",
              "48   Evaluation and Management (E/M) Visits\\nE/M vi...  \n",
              "51   Geographic practice cost indices\\nGPCIs\\nWork ...  \n",
              "54                    Skin substitutes\\nSynthetic skin  \n",
              "57                                                      \n",
              "63                                                      \n",
              "71                                                      \n",
              "78                                                      \n",
              "85   Rural Health Clinics (RHCs)\\nFederally Qualifi...  \n",
              "97   Rural Health Clinic Services Act of 1977\\nCAA ...  \n",
              "98   Clinical diagnostic laboratory tests\\nCDLT\\nLa...  \n",
              "101  Pulmonary rehabilitation\\nCardiac rehabilitati...  \n",
              "102  Section 2005\\nSUPPORT Act\\nOUD (opioid use dis...  \n",
              "105  MSSP\\nShared savings \\nACO(s)\\naccountable car...  \n",
              "106  Medicare Part B\\nPreventive vaccines\\nPneumoco...  \n",
              "110  Medicare Diabetes Prevention Program\\nMDPP\\nMD...  \n",
              "111  Appropriate use criteria\\nAUC\\nClinical decisi...  \n",
              "112  Provider, Enrollment, Chain and Ownership Syst...  \n",
              "113  HbA1c\\nA1c\\nDefinition of diabetes \\nHemoglobi...  \n",
              "114  SUPPORT Act\\nCMS EPCS Program\\nPrescription Dr...  \n",
              "115  ambulance services\\nambulance fee schedule (AF...  \n",
              "116  TEFRA\\n1861(dd)\\nconditions of participation (...  \n",
              "117  CLIA of 1988\\nHistopathology\\nIHC staining\\nH&...  \n",
              "118  Immigration status\\npremium tac credit\\nCost-s...  \n",
              "119  Health IT certification\\nIT\\nMedicaid\\nOffice ...  \n",
              "120  Annual Wellness Visit\\nAWV\\nSocial Determinant...  \n",
              "121                                                     \n",
              "126                          POS 10\\nnon-facility rate  \n",
              "127                                                     \n",
              "131                    no alternatives were considered  "
            ]
          },
          "execution_count": 3,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "#MODULE 1: Create data frame from the attached Topic/Subtopic file\n",
        "import pandas as pd\n",
        "Topic_SubTopic_df = pd.read_excel('Reference_Workbook_CY_Provisions_CY2024_DRS_Topics_Subtopics.xlsx')\n",
        "\n",
        "# print the output\n",
        "print(Topic_SubTopic_df.columns)\n",
        "Topic_only_df = Topic_SubTopic_df[Topic_SubTopic_df['InsightsAI_Topic'].notnull()]\n",
        "\n",
        "Topic_only_df.drop(columns=['Topic','Subtopic', 'Topic-Subtopic','InsightsAI_Subtopic','InsightsAI_TopicSubtopic'], inplace=True)\n",
        "\n",
        "Topic_only_df\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "YDl_nWXcgou2",
        "outputId": "fbeb6bf9-7561-4b99-9315-279b2118775d"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: PyPDF2 in /usr/local/lib/python3.10/dist-packages (3.0.1)\n",
            "<class 'list'>\n"
          ]
        }
      ],
      "source": [
        "# MODULE 2: Convert Proposed Rules PDF to Text\n",
        "!pip install PyPDF2\n",
        "import PyPDF2\n",
        "\n",
        "def convert_pdf_to_txt(file):\n",
        "    pdf_file = open(file, 'rb')\n",
        "    read_pdf = PyPDF2.PdfReader(pdf_file)\n",
        "    number_of_pages = len(read_pdf.pages)\n",
        "\n",
        "    segments = []\n",
        "    for page_number in range(number_of_pages):\n",
        "        page = read_pdf.pages[page_number]\n",
        "        page_content = page.extract_text()\n",
        "        segments.append(page_content)\n",
        "\n",
        "    return segments\n",
        "\n",
        "segments = convert_pdf_to_txt('CMS-2023-0121-0001_content_1920pp.pdf')\n",
        "print(type(segments))  # Output: <class 'list'>\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 206
        },
        "id": "g5WbmuV0tQ4O",
        "outputId": "bfcd4043-f092-40d4-975b-dd323874ade1"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"pages_df\",\n  \"rows\": 1920,\n  \"fields\": [\n    {\n      \"column\": \"page_number\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 554,\n        \"min\": 1,\n        \"max\": 1920,\n        \"num_unique_values\": 1920,\n        \"samples\": [\n          999,\n          1622,\n          612\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Text\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1910,\n        \"samples\": [\n          \"HCPCS \\nCode2021 Total \\nMedicare \\nAllowed \\nAmountPercent \\nUnits \\nDiscardedExcluded (Y/N) Applicable percentage % Exceeding \\napplicable \\npercentageEstimated \\nannual refundEstimated quarterly \\nrefund\\nJ3300 $8,964,090.01 10.97% N 90% proposed\\nJ0122 $144,528.76 10.84% N 10% 0.84% $1,214.04 $303.51 \\nJ3101 $12,921,647.56 10.67% N 10% 0.67% $86,575.04 $21,643.76 \\nJ9315 $23,154,637.13 10.33% Y; multiple \\nsource10%\\nJ9269 $7,755,186.19 10.15% N 26% proposed \\nJ9352 $9,225,195.63 10.10% N 10% 0.10% $9,225.20 $2,306.30 \\nQ4121 $6,484,123.19 17.85% Y; skin substitute\\n(proposed)10% 7.85%\\nQ4106 $1,511,046.28 16.64% Y; skin substitute\\n(proposed)10% 6.64%\\nQ4101 $2,176,035.02 14.58% Y; skin substitute\\n(proposed)10% 4.58%\\nTOTAL $82,883,368.59 $20,720,842.15\",\n          \"requirement to mean in-person, physical, not virtual, availability (please see the April 6, 2020 \\nIFC (85 FR 19245) and the CY 2022 PFS final rule (86 FR 65062)). Through the March 31, \\n2020 COVID-19 IFC, we changed the definition of \\u201cdirect supervision\\u201d during the PHE for \\nCOVID-19 (85 FR 19245 through 19246) as it pertains to supervision of diagnostic tests, \\nphysicians' services, and some hospital outpatient services, to allow the supervising professional \\nto be immediately available through virtual presence using two-way, real-time audio/video \\ntechnology, instead of requiring their physical presence. In the CY 2021 PFS final rule (85 FR \\n84538 through 84540), we finalized continuation of this policy through the later of the end of the \\ncalendar year in which the PHE for COVID-19 ends or December 31, 2021. In the March 31, \\n2020 IFC (85 FR 19246) and in our CY 2022 PFS final rule (see 85 FR 65063), we also noted \\nthat the temporary exception to allow immediate availability for direct supervision through \\nvirtual presence facilitates the provision of Medicare telehealth services by clinical staff of \\nphysicians and other practitioners\\u2019 incident to their own professional services. This is especially \\nrelevant for services such as physical therapy, occupational therapy, and speech language \\npathology services, since those practitioners were previously only able to bill Medicare for \\ntelehealth services under Medicare telehealth waivers that were effective during the PHE for \\nCOVID-19 (based on the emergency waiver authority established in section 1135(b)(8) of the \\nAct), until the CAA, 2023 extended the time period during which these practitioners could bill \\nfor Medicare telehealth services through December 31, 2024. We noted that sections \\n1834(m)(4)(D) and (E) of the Act specify the types of clinicians who may furnish and bill for \\nMedicare telehealth services. After December 31, 2024, the types of clinicians who may furnish \\nand bill for Medicare telehealth services include only physicians as defined in section 1861(r) of \\nthe Act and practitioners described in section 1842(b)(18)(C) of the Act. We note that this will \\ninclude mental health counselors (MHCs) and marriage and family therapists (MFTs) beginning \\nJanuary 1, 2024.\",\n          \"E.7 Controlling High Blood Pressure\\nCategory Description\\nCBE # N/A \\nQuality #:236 (as previously associated with a Quality # prior to the sunset of the CMS Web Interface collection type under MIPS that \\nbecame effective starting with the CY 2023 performance period)\\nCMS Web Interface ID: HTN-2\\nCurrent Collection Type: CMS Web Interface\\nCurrent Measure \\nDescription:Percentage of patients 18-85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or \\nstarting during the first six months of the measurement period, and whose most recent blood pressure was adequately controlled \\n(<140/90mmHg) during the measurement period.\\nSubstantive Change:The measure initial patient population is revised to read: Patients 18-85 years of age who had a visit during the measurement \\nperiod and diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the \\nmeasurement period. \\nUpdated denominator exclusion: Added: Dementia combinations: Donepezil-memantine to list of dementia exclusion \\nmedications.\\nUpdated guidance: Revised: In reference to the numerator element, only blood pressure readings performed by a clinician or an \\nautomated blood pressure monitor or device are acceptable for numerator compliance with this measure. This includes blood \\npressures taken in person by a clinician and blood pressures measured remotely by electronic monitoring devices capable of \\ntransmitting the blood pressure data to the clinician. Blood pressure readings taken by an automated blood pressure monitor or \\ndevice and conveyed by the patient to the clinician are also acceptable. It is the clinician\\u2019s responsibility and discretion to confirm \\nthe automated blood pressure monitor or device used to obtain the blood pressure is considered acceptable and reliable and \\nwhether the blood pressure reading is considered accurate before documenting it in the patient\\u2019s medical record.\\nUpdated numerator note: Revised: In reference to the numerator element, only blood pressure readings performed by a \\nclinician or an automated blood pressure monitor or device are acceptable for numerator compliance with this measure. This \\nincludes blood pressures taken in person by a clinician and blood pressures measured remotely by electronic monitoring devices \\ncapable of transmitting the blood pressure data to the clinician. Blood pressure readings taken by an automated blood pressure \\nmonitor or device and conveyed by the patient to the clinician are also acceptable. It is the clinician\\u2019s responsibility and discretion \\nto confirm automated blood pressure monitor or device used to obtain the blood pressure is considered acceptable and reliable \\nand whether the blood pressure reading is considered accurate before documenting it in the patient\\u2019s medical record.\\nMeasure Steward: National Committee for Quality Assurance\\nHigh Priority Measure: Yes\\nMeasure Type: Intermediate Outcome\\nRationale:We propose to revise the initial patient population to specify the patient visit must occur during the measurement period. This \\nrevision provides clarification of the encounter timing. \\nAdditionally, we propose to update the denominator exclusion to include Donepezil-memantine in the list of dementia medication \\nlist, as this is an applicable medication for the purposes of the denominator exclusion. This medication is used for patients with \\ndementia and therefore aligns with intent of the measure to exclude patients with this condition from the measure.\\nWe propose to revise the measure guidance and the numerator note around remote monitoring devices for capturing blood \\npressure readings. Currently, the measure allows patient reported data using most methods of digital collection/reporting and \\nprohibits patient reported data taken with non-digital devices, such as with a manual blood pressure cuff and stethoscope. The \\nmeasure is agnostic to how the reading gets in and the documentation practice of each office; therefore, whether patient is \\n\\u201cconveying the reading to the clinician\\u201d by manually entering the BP reading (for example, patient portal) or having the device \\nauto-transmit data directly, it is the clinician\\u2019s responsibility and discretion to confirm that the automated blood pressure monitor \\nused to obtain the blood pressure is considered acceptable and reliable.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "pages_df"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-9e2a9fe0-670c-458a-92ff-6f5f8e0d98a0\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>page_number</th>\n",
              "      <th>Text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>1</td>\n",
              "      <td>&lt;PRORULE&gt;\\n&lt;PREAMB&gt;\\n \\nDEPARTMENT OF HEALTH A...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>2</td>\n",
              "      <td>plan under the Substance Use-Disorder Preventi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>3</td>\n",
              "      <td>Centers for Medicare &amp; Medicaid Services,\\nDep...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>4</td>\n",
              "      <td>MedicarePhysicianFeeSchedule@cms.hhs.gov, for ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>5</td>\n",
              "      <td>Sarah Fulton, (410) 786-2749, for issues relat...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-9e2a9fe0-670c-458a-92ff-6f5f8e0d98a0')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-9e2a9fe0-670c-458a-92ff-6f5f8e0d98a0 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-9e2a9fe0-670c-458a-92ff-6f5f8e0d98a0');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-68b09c29-42d0-4da4-8ce1-2b747d5c45d7\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-68b09c29-42d0-4da4-8ce1-2b747d5c45d7')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-68b09c29-42d0-4da4-8ce1-2b747d5c45d7 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   page_number                                               Text\n",
              "0            1  <PRORULE>\\n<PREAMB>\\n \\nDEPARTMENT OF HEALTH A...\n",
              "1            2  plan under the Substance Use-Disorder Preventi...\n",
              "2            3  Centers for Medicare & Medicaid Services,\\nDep...\n",
              "3            4  MedicarePhysicianFeeSchedule@cms.hhs.gov, for ...\n",
              "4            5  Sarah Fulton, (410) 786-2749, for issues relat..."
            ]
          },
          "execution_count": 5,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "#ALT mod 2- CREATE A DATA FRAME with pages\n",
        "import pandas as pd\n",
        "\n",
        "def convert_pdf_to_df(file):\n",
        "    pdf_file = open(file, 'rb')\n",
        "    read_pdf = PyPDF2.PdfReader(pdf_file)\n",
        "    number_of_pages = len(read_pdf.pages)\n",
        "\n",
        "    page_data = []  # List to store data for each page\n",
        "    for page_number in range(number_of_pages):\n",
        "        page = read_pdf.pages[page_number]\n",
        "        page_content = page.extract_text()\n",
        "        page_data.append({'page_number': page_number + 1, 'Text': page_content})  # Use page_number + 1 for 1-based indexing\n",
        "\n",
        "    # Create a DataFrame with the page data\n",
        "    pages_df = pd.DataFrame(page_data)\n",
        "\n",
        "    return pages_df\n",
        "\n",
        "# Example usage\n",
        "pages_df = convert_pdf_to_df('CMS-2023-0121-0001_content_1920pp.pdf')\n",
        "\n",
        "pages_df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "0vQqACl4lAlk",
        "outputId": "edc453a1-6b0d-4486-a548-39d4cd0d3f5c"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "The document has  1920  PAGES.\n",
            "\n",
            "Here is the first page: \n",
            "---------------------------------------------------------------------------------------------\n",
            "<PRORULE>\n",
            "<PREAMB>\n",
            " \n",
            "DEPARTMENT OF HEALTH AND HUMAN SERVICES\n",
            "Centers for Medicare & Medicaid Services\n",
            "42 CFR Parts 405, 410, 411, 414, 415, 418, 422, 423, 424, 425, 455, 489, 491, 495, 498, and \n",
            "600\n",
            "CMS-1784-P \n",
            "RIN 0938-AV07\n",
            "Medicare and Medicaid Programs; CY 2024 Payment Policies under the Physician Fee \n",
            "Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared \n",
            "Savings Program Requirements; Medicare Advantage; Medicare and Medicaid Provider \n",
            "and Supplier Enrollment Policies; and Basic Health Program\n",
            "AGENCY:  Centers for Medicare & Medicaid Services (CMS), Health and Human Services \n",
            "(HHS).\n",
            "ACTION:  Proposed rule. \n",
            "SUMMARY:  This major proposed rule addresses: changes to the physician fee schedule (PFS); \n",
            "other changes to Medicare Part B payment policies to ensure that payment systems are updated \n",
            "to reflect changes in medical practice, relative value of services, and changes in the statute; \n",
            "payment for dental services inextricably linked to specific covered medical services; Medicare \n",
            "Shared Savings Program requirements; updates to the Quality Payment Program; Medicare \n",
            "coverage of opioid use disorder services furnished by opioid treatment programs; updates to \n",
            "certain Medicare and Medicaid provider and supplier enrollment policies, electronic prescribing \n",
            "for controlled substances for a covered Part D drug under a prescription drug plan or an MA-PD This document is scheduled to be published in the\n",
            "Federal Register on 08/07/2023 and available online at\n",
            "federalregister.gov/d/2023-14624 , and on govinfo.gov\n",
            "---------------------------------------------------------------------------------------------\n"
          ]
        }
      ],
      "source": [
        "print(\"The document has \",len(segments), \" PAGES.\")\n",
        "print()\n",
        "print(\"Here is the first page: \")\n",
        "print(\"---------------------------------------------------------------------------------------------\")\n",
        "print(pages_df.Text[0] )\n",
        "print(\"---------------------------------------------------------------------------------------------\")\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "NpJONehbllG1"
      },
      "outputs": [],
      "source": [
        "#MODULE 3\n",
        "#installations for the model below\n",
        "!pip install transformers\n",
        "!pip install -U sentence-transformers\n",
        "!pip install nltk\n",
        "!pip install openai\n",
        "!pip install tiktoken"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "H714b28yvW_G",
        "outputId": "c864ccf0-4a3c-459c-a44a-0e9bc4465a0a"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Package punkt is already up-to-date!\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "['from p. 6: [Amy Gruber, (410) 786-1542, or AmbulanceDataCollection@cms.hhs.gov, for issues \\nrelated to the Ambulance Fee Schedule (AFS) and the Medicare Ground Ambulance Data \\nCollection System.]', 'from p. 6: [Mary Rossi-Coajou (410) 786-6051, for issues related to hospice Conditions of \\nParticipation.]', 'from p. 6: [Cameron Ingram (410) 409-8023 for issues related to Histopathology, Cytology, and \\nClinical Cytogenetics Regulations under CLIA of 1988.]', 'from p. 6: [Meg Barry (410)786-1536, for issues related to the Basic Health Program (BHP) \\nprovisions.]', 'from p. 6: [Renee ONeill, (410) 786-8821, or Sophia Sugumar, (410) 786-1648, for inquiries related \\nto Merit-based Incentive Payment System (MIPS).]']\n"
          ]
        }
      ],
      "source": [
        "#MODULE 4: Separate Document into Sentences with Page Information and then add the Topic\n",
        "import nltk\n",
        "nltk.download('punkt')\n",
        "from nltk.tokenize import sent_tokenize\n",
        "\n",
        "sentences_with_pages = []\n",
        "page_number = 1\n",
        "\n",
        "for page_content in segments:\n",
        "    page_sentences = sent_tokenize(page_content)\n",
        "    for sentence in page_sentences:\n",
        "        sentences_with_pages.append(f\"from p. {page_number}: [{sentence}]\")\n",
        "    page_number += 1\n",
        "\n",
        "print(sentences_with_pages[50:55])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "B8HrvBEPFpRS",
        "outputId": "2d8643c4-8d3c-467d-aa68-61769254fc0d"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "The document has  18988  SENTENCES. (The tool uses a period, '.', as the sentence delimeter.)\n",
            "\n",
            "Here is the LAST sentence: \n",
            "---------------------------------------------------------------------------------------------\n",
            "['from p. 1920: [2023-14624 Filed: 7/13/2023 4:15 pm; Publication Date:  8/7/2023]]']\n",
            "---------------------------------------------------------------------------------------------\n"
          ]
        }
      ],
      "source": [
        "print(\"The document has \",len(sentences_with_pages), \" SENTENCES. (The tool uses a period, '.', as the sentence delimeter.)\")\n",
        "print()\n",
        "print(\"Here is the LAST sentence: \")\n",
        "print(\"---------------------------------------------------------------------------------------------\")\n",
        "print(sentences_with_pages[-1:] )\n",
        "print(\"---------------------------------------------------------------------------------------------\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 371
        },
        "id": "XhgyqdrYvqRg",
        "outputId": "b0f22724-3c16-4c11-8b81-860e1b035936"
      },
      "outputs": [
        {
          "ename": "ValueError",
          "evalue": "module functions cannot set METH_CLASS or METH_STATIC",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mValueError\u001b[0m                                Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-11-d9d0071aaf54>\u001b[0m in \u001b[0;36m<cell line: 8>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      6\u001b[0m \u001b[0;31m#NOTE: THIS CAN RUN FOR SEVERAL (~10-15) MINUTES\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      7\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mpickle\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 8\u001b[0;31m \u001b[0;32mfrom\u001b[0m \u001b[0msentence_transformers\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mSentenceTransformer\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      9\u001b[0m \u001b[0mmodel\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mSentenceTransformer\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'all-MiniLM-L6-v2'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     10\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/sentence_transformers/__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0m__version__\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m\"2.7.0\"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      2\u001b[0m \u001b[0m__MODEL_HUB_ORGANIZATION__\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m\"sentence-transformers\"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 3\u001b[0;31m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mdatasets\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mSentencesDataset\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mParallelSentencesDataset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      4\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mLoggingHandler\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mLoggingHandler\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mSentenceTransformer\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mSentenceTransformer\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/sentence_transformers/datasets/__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mDenoisingAutoEncoderDataset\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mDenoisingAutoEncoderDataset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      2\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mNoDuplicatesDataLoader\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mNoDuplicatesDataLoader\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mParallelSentencesDataset\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mParallelSentencesDataset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mSentencesDataset\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mSentencesDataset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mSentenceLabelDataset\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mSentenceLabelDataset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/sentence_transformers/datasets/DenoisingAutoEncoderDataset.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0;32mfrom\u001b[0m \u001b[0mtorch\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mutils\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdata\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mDataset\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      2\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0mtyping\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mList\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mreaders\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mInputExample\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mInputExample\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mnumpy\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0mnp\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0mtransformers\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mutils\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mimport_utils\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mis_nltk_available\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mNLTK_IMPORT_ERROR\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/torch/__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m    235\u001b[0m     \u001b[0;32mif\u001b[0m \u001b[0mUSE_GLOBAL_DEPS\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    236\u001b[0m         \u001b[0m_load_global_deps\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 237\u001b[0;31m     \u001b[0;32mfrom\u001b[0m \u001b[0mtorch\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_C\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0;34m*\u001b[0m  \u001b[0;31m# noqa: F403\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    238\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    239\u001b[0m \u001b[0;31m# Appease the type checker; ordinarily this binding is inserted by the\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mValueError\u001b[0m: module functions cannot set METH_CLASS or METH_STATIC"
          ]
        }
      ],
      "source": [
        "#####################################################################################################################################################\n",
        "                    #MODULE 5.0 -- ONE TIME ONLY< EVER NEEDED PER DOCUMENT (then download the .pkl file, and uploaded it before running next module.)\n",
        "#####################################################################################################################################################\n",
        "\n",
        "#Build embedding for sentences using SentenceTransformer.\n",
        "#NOTE: THIS CAN RUN FOR SEVERAL (~10-15) MINUTES\n",
        "import pickle\n",
        "from sentence_transformers import SentenceTransformer\n",
        "model = SentenceTransformer('all-MiniLM-L6-v2')\n",
        "\n",
        "# This might take a while as it's processing a big document\n",
        "embeddings = model.encode(sentences_with_pages, convert_to_tensor=True)\n",
        "\n",
        "\n",
        "# Save embeddings, then BE SURE to download, since Google Colab won't save the file after the session ends.\n",
        "with open('embeddings.pkl', 'wb') as f:\n",
        "    pickle.dump(embeddings, f)\n",
        "\n",
        "#####################################################################################################################################################\n",
        "#####################################################################################################################################################"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "zfvoMZjTUb1d",
        "outputId": "08f18dbe-9977-454b-faad-148dca3b5e8e"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "18988"
            ]
          },
          "execution_count": 10,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "#MODULE 5 - after one-time run above, and uploading of .pkl file from localimport pickle\n",
        "# Load embeddings\n",
        "import pickle\n",
        "with open('embeddings.pkl', 'rb') as f:\n",
        "    embeddings = pickle.load(f)\n",
        "\n",
        "len(embeddings)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Y7T2YMicfbYS"
      },
      "outputs": [],
      "source": [
        "#Module 5b: Add Topics to segments\n",
        "import pandas as pd\n",
        "from nltk.tokenize import sent_tokenize\n",
        "#!pip install transformers --upgrade\n",
        "\n",
        "def num_tokens_from_string(string: str, encoding_name: str='gpt-4') -> int:\n",
        "    # Simulating encoding length function, adjust as needed\n",
        "    return len(string)\n",
        "\n",
        "def merge_with_topic(segments, Topic_only_df):\n",
        "  \"\"\"\n",
        "  Merges segments with topics based on page numbers and adds a 'Topic' column.\n",
        "\n",
        "  Args:\n",
        "      segments (list): List of page content strings.\n",
        "      Topic_only_df (pd.DataFrame): Dataframe with topics, start pages, and end pages.\n",
        "\n",
        "  Returns:\n",
        "      pd.DataFrame: Dataframe with segments, page numbers, and a 'Topic' column.\n",
        "  \"\"\"\n",
        "\n",
        "  # Initialize variables\n",
        "  page_number = 1\n",
        "  all_sentences = []\n",
        "\n",
        "  for page_content in segments:\n",
        "    # Tokenize sentences\n",
        "    page_sentences = sent_tokenize(page_content)\n",
        "    for sentence in page_sentences:\n",
        "      # Create a dictionary for each sentence with page and topic (initially None)\n",
        "      all_sentences.append({\n",
        "          'text': f\"from p. {page_number}: [{sentence}]\",\n",
        "          'page': page_number\n",
        "      })\n",
        "    page_number += 1\n",
        "\n",
        "\n",
        "\n",
        "  # Convert list of dictionaries to a dataframe\n",
        "  df_sentences = pd.DataFrame(all_sentences)\n",
        "\n",
        "  # Merge Dataframes\n",
        "  merged_df = df_sentences.merge(Topic_only_df, how='left', left_on='page', right_on='Start_Page')\n",
        "\n",
        "  # Forward fill 'Topic' and handle sentences exceeding last topic's end page\n",
        "  merged_df['InsightsAI_Topic'] = merged_df['InsightsAI_Topic'].fillna(method='ffill')\n",
        "  merged_df.loc[merged_df['page'] > Topic_only_df['End Page'].max(), 'InsightsAI_Topic'] = 'NA'\n",
        "\n",
        "  return merged_df\n",
        "\n",
        "merged_df = merge_with_topic(segments, Topic_only_df)\n",
        "\n",
        "merged_df = merged_df[merged_df['InsightsAI_Topic'].notnull()]\n",
        "#Remove stubborn last row:\n",
        "merged_df = merged_df[merged_df['InsightsAI_Topic']!=\"NA\"]\n",
        "\n",
        "\n",
        "\n",
        "### THIS OPTIONAL BLOCK OF CODE CAN ADD THE TOPIC TO THE ACTUAL TEXT BEING CONSIDERED.\n",
        "merged_df['text'] = 'Topic: ' + merged_df['InsightsAI_Topic'].astype(str) + ': [' + merged_df['text'] + ']'\n",
        "merged_df = merged_df.loc[:, ['text', 'page','InsightsAI_Topic']]\n",
        "\n",
        "###\n",
        "#merged_df[\"Topic_and_Text\"]=merged_df['InsightsAI_Topic']+merged_df['text']\n",
        "#Remove the single (And long) Non-Contiguous section of text pages\n",
        "merged_df = merged_df[~merged_df['page'].isin([i for i in range(869, 1175)])]\n",
        "\n",
        "#len(merged_df.text)\n",
        "merged_df.head()\n",
        "\n",
        "# Aggregate text for each Topic into a single entry\n",
        "merged_df_Topic_text_combined = merged_df.groupby('InsightsAI_Topic')['text'].agg(lambda x: ' '.join(x)).reset_index()\n",
        "\n",
        "#Count tokens for later summarization task (gpt4-turbo takes 128k tokens)\n",
        "from transformers import GPT2TokenizerFast\n",
        "tokenizer = GPT2TokenizerFast.from_pretrained('Xenova/gpt-4')\n",
        "\n",
        "def num_tokens_from_string(text: str) -> int:\n",
        "    # Tokenize the text using the GPT-4 tokenizer\n",
        "    tokens = tokenizer.tokenize(text)\n",
        "    return len(tokens)\n",
        "\n",
        "# Count tokens for later summarization task\n",
        "min_obs_show=0\n",
        "for index, text in enumerate(merged_df_Topic_text_combined['text'], start=1):\n",
        "    token_count = num_tokens_from_string(text)\n",
        "    if token_count >= min_obs_show:  # Add a condition to check for token count\n",
        "        print(f\"Row {index}: {token_count} tokens\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 206
        },
        "id": "lUhWg7c3UJae",
        "outputId": "a322dbe9-0c1f-4d0b-da96-ea643fe8560c"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"merged_df\",\n  \"rows\": 9837,\n  \"fields\": [\n    {\n      \"column\": \"text\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 9809,\n        \"samples\": [\n          \"Topic: 3G_MSSP: [from p. 548: [++  99495 and 99496 (codes for transitional care management services).]]\",\n          \"Topic: 3H_Part B Payment Preventive Vaccine: [from p. 689: [We explained that our goal would be better served if our policies with respect to \\n229 https://www.cms.gov/medicare/medicare-fee-for-service-part-b-\\ndrugs/mcrpartbdrugavgsalesprice/vaccinespricing.]]\",\n          \"Topic: 2E_Valuation of Specific Codes: [from p. 161: [In October 2021, the CPT Editorial Panel approved the addition of CPT code 76883 \\n(Ultrasound, nerve(s) and accompanying structures throughout their entire anatomic course in \\none extremity, comprehensive, including real-time cine imaging with image documentation, per \\nextremity) for reporting real-time, complete neuromuscular ultrasound of nerves and \\naccompanying structures throughout their anatomic course, per extremity, and the revision of \\nCPT code 76882 to add focal evaluation.]]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"page\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 356,\n        \"min\": 12,\n        \"max\": 1299,\n        \"num_unique_values\": 982,\n        \"samples\": [\n          821,\n          812,\n          1179\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"InsightsAI_Topic\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 33,\n        \"samples\": [\n          \"7E_Other Provisions in the Regulation\",\n          \"3F_OUD OTP Coverage\",\n          \"3Q_Changes to the Basic Health Program Regulations\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "merged_df"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-bc917b59-f42b-48d4-9656-60bb4f091a45\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>text</th>\n",
              "      <th>page</th>\n",
              "      <th>InsightsAI_Topic</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>140</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>12</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>141</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>12</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>142</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>12</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>12</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>144</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>12</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-bc917b59-f42b-48d4-9656-60bb4f091a45')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-bc917b59-f42b-48d4-9656-60bb4f091a45 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-bc917b59-f42b-48d4-9656-60bb4f091a45');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-baa577b6-db3f-44b0-a89c-774080a39f69\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-baa577b6-db3f-44b0-a89c-774080a39f69')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-baa577b6-db3f-44b0-a89c-774080a39f69 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                                                  text  page  \\\n",
              "140  Topic: 2B_Determination of Practice Expense RV...    12   \n",
              "141  Topic: 2B_Determination of Practice Expense RV...    12   \n",
              "142  Topic: 2B_Determination of Practice Expense RV...    12   \n",
              "143  Topic: 2B_Determination of Practice Expense RV...    12   \n",
              "144  Topic: 2B_Determination of Practice Expense RV...    12   \n",
              "\n",
              "                              InsightsAI_Topic  \n",
              "140  2B_Determination of Practice Expense RVUs  \n",
              "141  2B_Determination of Practice Expense RVUs  \n",
              "142  2B_Determination of Practice Expense RVUs  \n",
              "143  2B_Determination of Practice Expense RVUs  \n",
              "144  2B_Determination of Practice Expense RVUs  "
            ]
          },
          "execution_count": 12,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "merged_df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "d4JPAfy54M4r",
        "outputId": "d2158634-a9a6-45a1-df4a-c4757b4578a8"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "['from p. 48: [In light of the considerations discussed above, we request feedback on the following:\\n(1) If CMS should consider aggregating data for certain physician specialties to generate \\nindirect allocators so that PE/HR calculations based on PPIS data would be less likely to over-\\nallocate (or under-allocate) indirect PE to a given set of services, specialties, or practice types.]',\n",
              " 'from p. 48: [Our current methodology relies on \\nthe AMA PPIS data, legislatively mandated supplemental data sources (for, example, we use \\nsupplemental survey data collected in 2003, as required by section 1848(c)(2)(H)(i) of the Act to \\nset rates for oncology and hematology specialties), and in some cases crosswalks to allocate \\nindirect PE as necessary for certain specialties and provider types.]',\n",
              " 'from p. 44: [Background\\nThe AMA PPIS was first introduced in 2007 as a means to collect comprehensive and \\nreliable data on the direct and indirect PEs incurred by physicians (72 FR 66222).]',\n",
              " 'from p. 13: [The AMA administered a \\nnew survey in CY 2007 and CY 2008, the Physician Practice Information Survey (PPIS).]',\n",
              " \"from p. 1143: [TABLE 78: Estimated Burden for Quality Performance Category: Clinicians \\n(Participating Individually or as Part of a Group) Using the MIPS CQM and QCDR \\nCollection Type\\nBurden and Respondent DescriptionsBurden \\nEstimate\\n# of clinicians submitting as individuals (a) 11,197\\n# of groups submitting via QCDR or MIPS CQM on behalf of individual clinicians (b) 6,312\\nTotal # of Respondents (c) = (a) + (b) 17,509\\nHours Per Respondent to Report Quality Data (d) 3\\n# of Hours Medical and Health Services Manager Review Measure Specifications (e) 2\\n# of Hours Computer Systems Analyst Review Measure Specifications (f) 1\\n# of Hours LPN Review Measure Specifications (g) 1\\n# of Hours Billing Clerk Review Measure Specifications (h) 1\\n# of Hours Physician Review Measure Specifications (i) 1\\n# of Hours Per Respondent to Authorize Qualified Registry to Report on Respondent's \\nBehalf (j)0.083\\nAnnual Hours Per Respondent (k)= (d) + (e) + (f) + (g) + (h) + (i) + (j) 9.083\\nTotal Annual Hours (l) = (c)*(k) 159,034\\nCost Per Respondent to Submit Quality Data (@ computer systems analysts labor rate of \\n$103.40/hr) (m)$310.20\\nCost to Review Measure Specifications (@ medical and health services manager's labor \\nrate of $123.06/hr) (n)$246.12\\nCost Computer Systems Analyst Review Measure Specifications (@ computer systems \\nanalysts labor rate of $103.40/hr) (o)$103.40\\nCost LPN Review Measure Specifications (@ LPN's labor rate of $53.72/hr) (p) $53.72\\nCost Billing Clerk Review Measure Specifications (@ clerks labor rate of $43.08/hr) (q) $43.08\\nCost Physician Review Measure Specifications (@ physicians labor rate of $274.44/hr) \\n(r)$274.44\\nCost for Respondent to Authorize Qualified Registry/QCDR to Report on Respondent's \\nBehalf (@ computer systems analysts labor rate of $103.40/hr) (s)$8.58\\nTotal Annual Cost Per Respondent (t) = (m) + (n) + (o) + (p) + (q) + (r) + (s) $1,039.54\\nTotal Annual Cost (u) = (c) * (t) $18,201,306\\nIn Table 79, we calculated the net change in estimated burden for quality performance \\ncategory submissions using the MIPS CQM and QCDR collection type by using the currently \\napproved burden in the CY 2023 PFS final rule (87 FR 70151 through 70153).]\",\n",
              " 'from p. 44: [In the responses, we acknowledged concerns about potential gaps in \\nthe data, which could impact the allocation of indirect PE for certain physician specialties and \\nsuppliers, which are issues that remain important today.]',\n",
              " \"from p. 1876: [IA_AHE_3: Promote Use of Patient-Reported Outcome Tools\\nIA_AHE_5: MIPS Eligible Clinician Leadership in Clinical Trials or CBPR\\nIA_BE_4: Engagement of patients through implementation of improvements in patient portal\\nIA_BE_15: Engagement of Patients, Family, and Caregivers in Developing a Plan of Care\\nIA_CC_1: Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop\\nIA_CC_13: Practice Improvements to Align with OpenNotes Principles \\nIA_EPA_1: Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's \\nMedical Record\\nIA_MVP: Practice-Wide Quality Improvement in MIPS Value Pathways\\nIA_PCMH: Electronic submission of Patient Centered Medical Home accreditation\\nIA_PM_16: Implementation of medication management practice improvements\\nIA_PSPA_7: Use of QCDR data for ongoing practice assessment and improvements\\nCost Measures\\nWe propose to include one MIPS cost measure within the cost performance category of this MVP, which applies to the clinical \\ntopic of otolaryngology.]\",\n",
              " 'from p. 48: [(2) Whether  aggregations of services, for purposes of assigning PE inputs, represent a \\nfair, stable and accurate means to account for indirect PEs across various specialties or practice \\ntypes?]',\n",
              " 'from p. 44: [The data collection process included a stratified random sample of physicians across \\nvarious specialties, and the survey was administered between August 2007 and March 2008.]',\n",
              " 'from p. 16: [  Then, we incorporate the specialty specific indirect PE/HR data into the calculation.]']"
            ]
          },
          "execution_count": 19,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "# MODULE 6a: Find Sentences Related to a given Comment\n",
        "from torch.nn import CosineSimilarity\n",
        "import torch\n",
        "from sentence_transformers import SentenceTransformer\n",
        "model = SentenceTransformer('all-MiniLM-L6-v2') #same model as above\n",
        "\n",
        "cos_sim = CosineSimilarity()\n",
        "\n",
        "# Function to find related sentences with page information\n",
        "def find_related_sentences(comment):\n",
        "    comment_embedding = model.encode([comment], convert_to_tensor=True)\n",
        "    similarities = cos_sim(comment_embedding, embeddings)\n",
        "    top_related_idx = torch.topk(similarities, k=10).indices\n",
        "    related_sentences = [sentences_with_pages[idx] for idx in top_related_idx]\n",
        "    return related_sentences\n",
        "\n",
        "# Test it with an example comment\n",
        "comment=\"\"\"[BEGIN MC COMMENT: Soliciting Public Comment on Strategies for Updates to Practice Expense Data Collection Methodology\n",
        "In the Proposed Rule, CMS included five questions related to the AMA PPI Survey:\n",
        "\n",
        "a.\tIf CMS should consider aggregating data for certain physician specialties to generate indirect allocators so that PE/HR calculations based on PPI survey data would be less likely to over- allocate (or under-allocate) indirect PE to a given set of services, specialties, or practice types. Further, what thresholds or methodological approaches could be employed to establish such aggregations?\n",
        "The AMA PPI survey uses stratification to control the distribution of sampled cases, either to match the distribution of the population or to differ from it in a controlled way. The use of stratification will improve the precision of estimates, both overall and within subgroups defined by the stratification. The AMA recommends that CMS postpone any consideration of the level of granularity of specialty-level data until after the PPI demonstrates the differences and similarities of practice costs by specialty. The AMA and Mathematica could consider recommendations related to this question once the study is completed.\n",
        "\n",
        "b.\tWhether aggregations of services, for purposes of assigning PE inputs, represent a fair, stable, and accurate means to account for indirect PE across various specialties or practice types?\n",
        "The AMA believes that it is important for the CMS practice expense methodology to have a sufficient level of granularity to reflect actual practice costs incurred by physician practices. Ambulatory payment classification (APC) codes from the OPPS, for example, would not represent a fair, stable, and accurate means to account for indirect practice expense for the MFS due to lack of granularity.\n",
        "\n",
        "Resource costs in the MFS are developed through an extremely granular bottom-up methodology in which the necessary resource costs are added line-by-line to achieve the actual costs for the physician to provide the care. In contrast, payment to facilities under the OPPS is calculated on the geometric mean of the costs of services in the same APC codes. To equate the rigorously developed line-item costs associated with services performed in the non-facility setting, with charges that are intended to be an average of similar services when performed in the facility is severely flawed because the two systems are making payments under vastly different assumptions.\n",
        "While hospital charge information is updated on a rolling basis, it does not mean that these cost data are more accurate. Under the OPPS, each APC is assigned a cost weight based on the geometric mean costs of all the procedures assigned to that APC. These estimated costs are derived from hospital charges adjusted to costs using each hospitals cost to charge ratio (CCR). Rather than estimating the costs of each resource on a per line-item basis, this ratio is an average at the hospital department level. Since the creation of the OPPS, this averaging mechanism has consistently resulted in charge compression. CMS defines charge compression as the practice of applying a lower charge markup to higher cost services and a higher charge markup to lower cost services. As a result, the cost-based weights may reflect some aggregation bias, undervaluing high-cost items and overvaluing low-cost items when an estimate of average markup, embodied in a single CCR, is applied to items of widely varying costs in the same cost center.\n",
        "\n",
        "\n",
        "For the over 8,000 CPT/Healthcare Common Procedure Coding System (HCPCS) codes that have Active or Restricted Coverage status the CY2024 MFS NPRM Addendum B, there are only 162 unique APC codes in the CY2024 OPPS NPRM addendum B. Over 3,000 of the CPT/HCPCS codes that are Active or have Restricted Coverage status do not even have an assigned APC code.\n",
        "\n",
        "c.\tIf and how CMS should balance factors that influence indirect PE inputs when these factors are likely driven by a difference in geographic location or setting of care, specific to individual practitioners (or practitioner types) versus other specialty/practice specific characteristics (for example, practice size, patient population served)?\n",
        "In the PPI study, the AMA and Mathematica are controlling the number of sampled practices within strata defined by (1) specialty, (2) proportion of time in the facility setting, (3) practice size, (4) ownership type (individual ownership vs. more complex ownership types), (5) geographic region, and among practices with complex ownership, whether (6) the practice is part of a vertically integrated health system, and (7) private equity ownership.\n",
        "\n",
        "The AMA and Mathematica are using these criteria for our Initial sampling, and if there is variance in the response rates between different practice types, we will also use these criteria to adjust the sampling midway through the data collection period. Finally, the AMA and Mathematica will develop final analysis weights to adjust for the probability of selection, practice eligibility, and cooperation, ensuring selected weighted totals match marginal population totals from the sample frame. In the survey itself, participating practices are asked to split out their provider compensation and time, staffing and other direct and indirect practice expenses at the Medicare specialty level, if possible.\n",
        "The AMA and Mathematica could provide recommendations related to this question once the PPI survey is completed. The PPI sampling and weighting methodology should account for most of these factors.\n",
        "\n",
        "d.\tWhat possible unintended consequences may result if CMS were to act upon the respondents recommendations for any of highlighted considerations above?\n",
        "Medicare payment differentials between the MFS and the OPPS are significant and have been growing, and this may be a factor in the decline in private practice. In fact, physician survey data indicate that payment and practice costs are two of the three leading reasons for private practices selling to hospitals or health systems.3 It is important to ensure that any potential changes to CMS practice expense methodology do not further exacerbate this relationship and instead work towards correcting site of service inconsistencies.\n",
        "\n",
        "In last years NPRM, CMS provided an impact table related to the initiative of rebasing and revising the MEI weights. CMS noted that implementation of that change in the PE methodology would have shifted payment weights from physician work to practice expense principally favoring Diagnostic Testing Facility (+13 percent), Portable X-Ray Supplier (+13 percent), Independent Laboratory (+10 percent), and Radiation Therapy Centers (+6 percent) to the detriment of Cardiothoracic Surgery (-8 percent), Neurosurgery (-8 percent), Emergency Medicine (-8 percent), and Anesthesiology (-5 percent). Modest increases occur to specialties who provide services in the office with extremely expensive disposable supplies embedded into physician payment. Primary Care would face decreases (Family Medicine (-1\n",
        "\n",
        "3 Kane CK. Recent Changes in Physician Practice Arrangements: Shifts Away from Private Practice and Towards Larger Practice Size Continue Through 2022. Chicago (IL): American Medical Association; 2023. Policy Research Perspective 2023. https://www.ama-assn.org/system/files/2022-prp-practice-arrangement.pdf\n",
        "\n",
        "\n",
        "percent), Geriatrics (-2 percent), Internal Medicine (-2 percent) and Pediatrics (-2 percent)). Similar to that separate policy change, other changes to the PE methodology would cause massive shifts between specialties, as well as within specialties, and put the solvency of many physician practices and other health care organizations in jeopardy. Any changes that are considered should be made carefully to ensure they reflect actual practice costs incurred by physician practices. All changes that impact physician practices should be phased in.\n",
        "\n",
        "e.\tWhether specific types of outliers or non-response bias may require different analytical approaches and methodological adjustments to integrate refreshed data?\n",
        "The AMA and Mathematica will develop final analysis weights to adjust for probability of selection, practice eligibility, and cooperation, ensuring selected weighted totals match marginal population totals from the sample frame. The AMA and Mathematica will evaluate the potential for nonresponse bias by conducting a nonresponse bias analysis. The AMA and Mathematica are using strata for our initial sampling, as described above. Also, if there is variance in the response rates between different practice types, these criteria will be utilized to adjust the sampling midway through the data collection period. END MC COMMENT]\n",
        "\"\"\"\n",
        "related_sentences = find_related_sentences(comment)\n",
        "text = \" \".join(related_sentences) + comment\n",
        "text\n",
        "#print(comment)\n",
        "related_sentences"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "UPGCHbxx9qv_",
        "outputId": "5b734cdf-1817-4575-db79-b2006fe5bb63"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "Special tokens have been added in the vocabulary, make sure the associated word embeddings are fine-tuned or trained.\n",
            "<ipython-input-28-2358c9500502>:63: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  TEST_merged_df_Topic_text_combined['Topic Summary'] = summarize_topics(TEST_merged_df_Topic_text_combined)\n"
          ]
        },
        {
          "data": {
            "text/html": [
              "\n",
              "    <style>\n",
              "        body {\n",
              "            font-family: \"Arial\", sans-serif;\n",
              "        }\n",
              "        .summary-container {\n",
              "            margin: 20px;\n",
              "            padding: 15px;\n",
              "            border-radius: 8px;\n",
              "            background-color: #f9f9f9;\n",
              "            box-shadow: 0 2px 4px rgba(0,0,0,0.1);\n",
              "        }\n",
              "        .topic-title {\n",
              "            color: #333;\n",
              "            font-size: 18px;\n",
              "        }\n",
              "        .summary-text {\n",
              "            color: #555;\n",
              "            font-size: 14px;\n",
              "            margin-top: 5px;\n",
              "        }\n",
              "    </style>\n",
              "    <div class=\"summary-container\">\n",
              "        <h2 style=\"color: #4B0082;\">Summary Overview</h2>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3H_Part B Payment Preventive Vaccine</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3I_MDPP</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3J_Appropriate Use Criteria for Advanced Diagnostic Imaging</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3K_Medicaid Provider Enrollment</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3L_Expand Diabetes Screening and Diabetes Definitions</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3M_EPCS Part D</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3N_Ambulance Fee and GADCS</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3O_Hospice: Changes to Conditions of Participation</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3P_Solicitation: Histopathology, Cytology, and Clinical Cytogenetics Regs under CLIA</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3Q_Changes to the Basic Health Program Regulations</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3R_Updates to the Definitions of CEHRT</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3S_SDOH Risk Assessment in the AWV</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7D_Changes Related to Telehealth Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7E_Other Provisions in the Regulation</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7F_Alternatives Considered</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7_Regulatory Impact Analysis</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div></div>"
            ],
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ]
          },
          "execution_count": 28,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "# MODULE 7B - ALT Summary as Topic Data Frame\n",
        "# Generate and present the final summary output in HTML format\n",
        "#!pip install openai --upgrade\n",
        "import openai\n",
        "from transformers import GPT2TokenizerFast\n",
        "from IPython.display import HTML\n",
        "import pandas as pd\n",
        "\n",
        "#Rf the 33 rows, need to skip Row 17 because of it's size. So run first 16, then last 16\n",
        "#TEST_merged_df_Topic_text_combined=merged_df_Topic_text_combined.iloc[16]\n",
        "TEST_merged_df_Topic_text_combined=merged_df_Topic_text_combined.tail(16)\n",
        "\n",
        "# Setup OpenAI API key\n",
        "openai.api_key = \"your open AI key\"\n",
        "\n",
        "\n",
        "#Count tokens for later summarization task (gpt4-turbo takes 128k tokens)\n",
        "tokenizer = GPT2TokenizerFast.from_pretrained('Xenova/gpt-4')\n",
        "def num_tokens_from_string(text: str) -> int:\n",
        "    # Tokenize the text using the GPT-4 tokenizer\n",
        "    tokens = tokenizer.tokenize(text)\n",
        "    return len(tokens)\n",
        "\n",
        "def get_gpt4_summary(text, prompt=\"\"):\n",
        "        input_text = f\"{text}\\n\\nPrompt: {prompt}\"\n",
        "        Char_length = len(input_text)\n",
        "        model_choice = \"gpt-4-turbo\" if num_tokens_from_string(input_text) > 7500 else \"gpt-4\"\n",
        "        response = openai.chat.completions.create(\n",
        "            model=model_choice,\n",
        "            messages=[{\"role\": \"user\", \"content\": input_text}],\n",
        "            max_tokens=600,\n",
        "            temperature=0.5,\n",
        "            n=1,\n",
        "        )\n",
        "        generated_summary = response.choices[0].message.content.strip()\n",
        "        return generated_summary\n",
        "\n",
        "def summarize_topics(row):\n",
        "    prompt = \"\"\"This is a summarization task. The input text is several sentences retrieved from a very large reference document.\n",
        "                Make your whole summary 500 words or less. Make the final output a VERY concise but coherent analysis of the question,\n",
        "                and what the text says, picking up the themes and patterns in the overall text.The text to be summarized will come as a series of bracketed sentences. Each sentence starts with a semi-coded Topic label (it will have an alphnumeric code and then an English language text description) followed by a colon, just before the braketed sentence.\n",
        "                In your summary output you do NOT need to re-state this topic; but it should be kept in mind as a guide to what the unified theme of the entire block text being summarized, since the Topic will be the same for all sentences within a given text block given for summarization.\n",
        "                One important way to use this topic in your summarization is to help you tp determine the relevance of a given sentence to the overall summary. This is PARTICULARLY important for the text at the first and last pages (pages are also indicated for each sentence), because the text has not been perfectly parsed by the Topic, so some of the\n",
        "                text at the very beginnning and very end of the text to summarize may be from a different Topic than what the summary is intended to describe. So just be careful not to add into your summary\n",
        "                something that is from one of the first or last sentences of the text and is obviously unrelated to the Topic. In each case the Topic will be a semi-coded label for the text comes directly after it it, as follows: \"2B_Determination of Practice Expense RVUs: [from p. 12:[This is an example sentence]] 2B_Determination of Practice Expense RVUs: [from p. 13:[This is another example sentence]]\"\n",
        "                2B_Determination of Practice Expense RVUs: [from p. 12:[This is an example sentence]]\n",
        "                The output needs to sections, clearly delineated: 'Background', and 'Provision'.\n",
        "                Please do NOT use any 'meta' language, i.e., do NOT introduce what you are going to say by saying things like 'here you will find that the text discusses the concept of'[...]\n",
        "                 when you could instead say 'this section concerns' or something even  more succinct. Do NOT 'break the 4th wall' by making unnecessry references to the reader or you the writer; or otherwise re-state points already made: just jump into the summary.\n",
        "                Also, you don't need to fully spell out the words used in Acronyms more than once, and for three specific common acronyms (in this context) you NEVER need to fully spell out what the letters stand for, just give the 3-letter acronym: AMA (for American Medical Association), CMS (for Center for Medicare and Medicaid Services), and CY (for Contract Year).\n",
        "                Here is an example of what need for summary output. But be carefull NOT to use this actual content word for word, or to copy ideas out of this example that do not relate to the text which you are being asked to summarize.\n",
        "                The example here is only meant to serve you as a STRUTCURAL and Linguistic STYLE example.:\n",
        "                Background:\n",
        "Practice Expense (PE) is the portion of resources used in furnishing a service that reflects the general categories of physician and practitioner expenses, such as office rent and personnel wages, but excluding malpractice (MP) expenses, as specified in section 1848(c)(1)(B) of the Act. PE RVUs are developed by considering the direct and indirect practice resources involved in furnishing each service. Direct expense categories include clinical labor, medical supplies, and medical equipment and are determined by adding the costs of the direct resources involved with furnishing that service. Indirect expenses include administrative labor, office expense, and all other expenses and are calculated using Physician Practice Expense Information Survey (PPIS) data that demonstrated the practice expenses incurred per hour worked. If a procedure can be done in a physician office and a facility setting, there are two PE RVUs: facility and non-facility. The CY 2010 PFS final rule, as well as the Calculations of PE RVUs under Methodology for Selected Codes file provides more detailed descriptions of the PE RVU methodology.\n",
        "The Medicare Economic Index (MEI) is an index that measures changes in the market price of inputs used to furnish physician services. Essentially, it is a measure that takes into account inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
        "\n",
        "Provision:\n",
        "CMS is proposing to NOT incorporate the finalized 2017-based MEI in PFS rate setting for CY 2024. This is due to AMAs intention to collect practice cost data from physician practices in the near future which could be used to derive cost share weights for the MEI and RVU shares, as well as the methodological and data source changes that could significantly impact PFS payments.\n",
        "                \"\"\"\n",
        "    return get_gpt4_summary(row['text'], prompt)\n",
        "\n",
        "# Apply summarization function to each row\n",
        "TEST_merged_df_Topic_text_combined['Topic Summary'] = summarize_topics(TEST_merged_df_Topic_text_combined)\n",
        "\n",
        "# Create final DataFrame\n",
        "Final_Topic_Summary_df = TEST_merged_df_Topic_text_combined[['InsightsAI_Topic', 'Topic Summary', 'text']]\n",
        "\n",
        "def generate_html_output(df):\n",
        "    html_content = '''\n",
        "    <style>\n",
        "        body {\n",
        "            font-family: \"Arial\", sans-serif;\n",
        "        }\n",
        "        .summary-container {\n",
        "            margin: 20px;\n",
        "            padding: 15px;\n",
        "            border-radius: 8px;\n",
        "            background-color: #f9f9f9;\n",
        "            box-shadow: 0 2px 4px rgba(0,0,0,0.1);\n",
        "        }\n",
        "        .topic-title {\n",
        "            color: #333;\n",
        "            font-size: 18px;\n",
        "        }\n",
        "        .summary-text {\n",
        "            color: #555;\n",
        "            font-size: 14px;\n",
        "            margin-top: 5px;\n",
        "        }\n",
        "    </style>\n",
        "    <div class=\"summary-container\">\n",
        "        <h2 style=\"color: #4B0082;\">Summary Overview</h2>'''\n",
        "\n",
        "    for _, row in df.iterrows():\n",
        "        html_content += f'''\n",
        "            <div>\n",
        "                <h3 class=\"topic-title\">Topic: {row[\"InsightsAI_Topic\"]}</h3>\n",
        "                <p class=\"summary-text\"><strong>Summary:</strong> {row[\"Topic Summary\"]}</p>\n",
        "            </div>'''\n",
        "\n",
        "    html_content += '</div>'\n",
        "    return HTML(html_content)\n",
        "\n",
        "\n",
        "# Call the function to display HTML output\n",
        "html_output = generate_html_output(Final_Topic_Summary_df)\n",
        "html_output\n",
        "# Display the final DataFrame\n",
        "#Final_Topic_Summary_df.head()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "35lZra4Cg1kx",
        "outputId": "a4728bf3-4237-4917-df2a-670309090a77"
      },
      "outputs": [
        {
          "data": {
            "text/html": [
              "\n",
              "    <style>\n",
              "        body {\n",
              "            font-family: \"Arial\", sans-serif;\n",
              "        }\n",
              "        .summary-container {\n",
              "            margin: 20px;\n",
              "            padding: 15px;\n",
              "            border-radius: 8px;\n",
              "            background-color: #f9f9f9;\n",
              "            box-shadow: 0 2px 4px rgba(0,0,0,0.1);\n",
              "        }\n",
              "        .topic-title {\n",
              "            color: #333;\n",
              "            font-size: 18px;\n",
              "        }\n",
              "        .summary-text {\n",
              "            color: #555;\n",
              "            font-size: 14px;\n",
              "            margin-top: 5px;\n",
              "        }\n",
              "    </style>\n",
              "    <div class=\"summary-container\">\n",
              "        <h2 style=\"color: #4B0082;\">Summary Overview</h2>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2B_Determination of Practice Expense RVUs</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2C_Potentially Misvalued Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2D_Telehealth Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2E_Valuation of Specific Codes</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2F_E&M Visits</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2G_Geographic Practice Cost Indices</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2H_Payment for Skin Substitutes</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2I_Supervision of OP Therapy Svcs, KX Modifier, DSMT Svcs, and DSMT Telehealth</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2J_Advancing Access to Behavioral Health Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2K_Medicare Parts A and B Payment for Dental Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3A_Drugs and Biological Products Paid Under Part B </h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3B_RHCs and FQHCs</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3C_RHCs and FQHCs Conditions for Certification or Coverage</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3D_Clinical Lab Fee Schedule</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3E_Pulm/Cardiac/Intensive Cardiac Rehab Expansion of Supervising Practitioners</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3F_OUD OTP Coverage</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are a measure of the resources utilized in providing a service, encompassing general physician expenses such as office rent and staff wages, but excluding malpractice costs. PE RVUs are calculated by adding the costs of direct resources involved in providing a service, including clinical labor, medical supplies, and medical equipment. Indirect expenses, such as administrative labor and office costs, are also factored in, using data from the Physician Practice Expense Information Survey (PPIS). If a procedure can be executed in both a physician's office and a facility setting, two PE RVUs are established: one for the facility and one for the non-facility. \n",
              "\n",
              "The Medicare Economic Index (MEI) is an index that monitors changes in the market price of inputs used to provide physician services, essentially accounting for inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS proposes not to incorporate the finalized 2017-based MEI in PFS rate setting. This decision is influenced by the AMA's upcoming collection of practice cost data from physician practices, which could be used to derive cost share weights for the MEI and RVU shares. Additionally, potential methodological and data source changes could significantly impact PFS payments.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: nan</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> nan</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: nan</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> nan</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: nan</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> nan</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3H_Part B Payment Preventive Vaccine</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3I_MDPP</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3J_Appropriate Use Criteria for Advanced Diagnostic Imaging</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3K_Medicaid Provider Enrollment</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3L_Expand Diabetes Screening and Diabetes Definitions</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3M_EPCS Part D</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3N_Ambulance Fee and GADCS</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3O_Hospice: Changes to Conditions of Participation</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3P_Solicitation: Histopathology, Cytology, and Clinical Cytogenetics Regs under CLIA</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3Q_Changes to the Basic Health Program Regulations</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3R_Updates to the Definitions of CEHRT</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3S_SDOH Risk Assessment in the AWV</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7D_Changes Related to Telehealth Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7E_Other Provisions in the Regulation</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7F_Alternatives Considered</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7_Regulatory Impact Analysis</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses various topics related to healthcare regulations and provisions. The first topic is about the Part B payment for preventive vaccines under Medicare. It also discusses the Medicare Diabetes Prevention Program (MDPP) which provides information on the expansion of the MDPP model test. The text also covers the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. It also discusses the expansion of diabetes screening and diabetes self-management training.\n",
              "\n",
              "The Electronic Prescribing for Controlled Substances (EPCS) under Medicare Part D is also covered. The text provides information on the Ambulance Fee Schedule (AFS) and the Ground Ambulance Data Collection System (GADCS). It also discusses changes to the conditions of participation for hospice providers and the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other topics include changes to the Basic Health Program (BHP) Blueprint, updates to the definitions of Certified EHR Technology (CEHRT), and the inclusion of social determinants of health (SDOH) risk assessment in the Annual Wellness Visit (AWV). The text also covers changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.\n",
              "\n",
              "Provision:\n",
              "The provisions discussed in the text include changes to the payment for preventive vaccines under Medicare Part B and the expansion of the MDPP model test. There are also provisions for the appropriate use criteria for advanced diagnostic imaging services and the requirement for Medicaid provider enrollment. Provisions for the expansion of diabetes screening and diabetes self-management training are also discussed. \n",
              "\n",
              "The text provides provisions for the EPCS under Medicare Part D, the AFS and GADCS, and changes to the conditions of participation for hospice providers. It also provides provisions for the solicitation for histopathology, cytology, and clinical pathology services. \n",
              "\n",
              "Other provisions include changes to the BHP Blueprint, updates to the definitions of CEHRT, and the inclusion of SDOH risk assessment in the AWV. The text also provides provisions for changes related to telehealth services, other provisions in the regulation, and alternatives considered in the regulatory impact analysis.</p>\n",
              "            </div></div>"
            ],
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ]
          },
          "execution_count": 40,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "#Final_Topic_Summary_df_1=Final_Topic_Summary_df\n",
        "#Final_Topic_Summary_df_3=Final_Topic_Summary_df\n",
        "\n",
        "concatenated_df = pd.concat([Final_Topic_Summary_df_1, Final_Topic_Summary_df_3, Final_Topic_Summary_df_2], ignore_index=True)\n",
        "concatenated_df\n",
        "html_output = generate_html_output(concatenated_df)\n",
        "html_output\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AHxub6pjGwn8",
        "outputId": "44bc625c-b564-4764-b047-d66417813ef2"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "Special tokens have been added in the vocabulary, make sure the associated word embeddings are fine-tuned or trained.\n",
            "Token indices sequence length is longer than the specified maximum sequence length for this model (154679 > 8192). Running this sequence through the model will result in indexing errors\n",
            "<ipython-input-34-2bd8a9240fca>:86: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  TEST_merged_df_Topic_text_combined['Topic Summary'] = summarize_topics(TEST_merged_df_Topic_text_combined)\n",
            "<ipython-input-34-2bd8a9240fca>:86: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  TEST_merged_df_Topic_text_combined['Topic Summary'] = summarize_topics(TEST_merged_df_Topic_text_combined)\n"
          ]
        },
        {
          "data": {
            "text/plain": [
              "InsightsAI_Topic                                              3G_MSSP\n",
              "Topic Summary       Background:\\nThe Medicare Shared Savings Progr...\n",
              "text                Topic: 3G_MSSP: [from p. 448: [audio-only visi...\n",
              "Name: 16, dtype: object"
            ]
          },
          "execution_count": 34,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "############### ALTERNATE EXPERIMENT# MODULE 7B - ALT Summary as Topic Data Frame\n",
        "# Generate and present the final summary output in HTML format\n",
        "#!pip install openai --upgrade\n",
        "import openai\n",
        "from transformers import GPT2TokenizerFast\n",
        "from IPython.display import HTML\n",
        "import pandas as pd\n",
        "\n",
        "#Rf the 33 rows, need to skip Row 17 because of it's size. So run first 16, then last 16\n",
        "#TEST_merged_df_Topic_text_combined=merged_df_Topic_text_combined\n",
        "TEST_merged_df_Topic_text_combined=merged_df_Topic_text_combined.iloc[16]\n",
        "\n",
        "# Setup OpenAI API key\n",
        "openai.api_key = \"your open AI key\"\n",
        "\n",
        "#Count tokens for later summarization task (gpt4-turbo takes 128k tokens)\n",
        "tokenizer = GPT2TokenizerFast.from_pretrained('Xenova/gpt-4')\n",
        "def num_tokens_from_string(text: str) -> int:\n",
        "    # Tokenize the text using the GPT-4 tokenizer\n",
        "    tokens = tokenizer.tokenize(text)\n",
        "    return len(tokens)\n",
        "\n",
        "def get_gpt4_summary(text, prompt=\"\"):\n",
        "    total_tokens = num_tokens_from_string(text)\n",
        "    if total_tokens <= 125000:\n",
        "        # If text is short enough, just pass it to the model\n",
        "        input_text = f\"{text}\\n\\nPrompt: {prompt}\"\n",
        "        model_choice = \"gpt-4-turbo\" if total_tokens > 7500 else \"gpt-4\"\n",
        "        response = openai.chat.completions.create(\n",
        "            model=model_choice,\n",
        "            messages=[{\"role\": \"user\", \"content\": input_text}],\n",
        "            max_tokens=600,\n",
        "            temperature=0.5,\n",
        "            n=1,\n",
        "        )\n",
        "        generated_summary = response.choices[0].message.content.strip()\n",
        "        return generated_summary\n",
        "    else:\n",
        "        if total_tokens > 250000:\n",
        "            raise ValueError(\"Input text is too long. Maximum of 250000 tokens are supported.\")\n",
        "\n",
        "        # Calculation to find the split point\n",
        "        split_at = total_tokens - 2 * (total_tokens - 125000)\n",
        "\n",
        "        # Split the tokens\n",
        "        tokens = tokenizer.tokenize(text)\n",
        "        part1_tokens = tokens[:split_at]\n",
        "        part2_tokens = tokens[split_at:]\n",
        "\n",
        "        # Convert tokens back to text\n",
        "        part1 = tokenizer.convert_tokens_to_string(part1_tokens)\n",
        "        part2 = tokenizer.convert_tokens_to_string(part2_tokens)\n",
        "\n",
        "        # Generate summaries for each part\n",
        "        summary1 = get_gpt4_summary(part1, prompt) # Use the same prompt for each part\n",
        "        summary2 = get_gpt4_summary(part2, prompt)\n",
        "\n",
        "        # Return the combined summary\n",
        "        return summary1 + \"\\n\" + summary2\n",
        "\n",
        "def summarize_topics(row):\n",
        "    prompt = \"\"\"This is a summarization task. The input text is several sentences retrieved from a very large reference document.\n",
        "                Make your whole summary 500 words or less. Make the final output a VERY concise but coherent analysis of the question,\n",
        "                and what the text says, picking up the themes and patterns in the overall text.The text to be summarized will come as a series of bracketed sentences. Each sentence starts with a semi-coded Topic label (it will have an alphnumeric code and then an English language text description) followed by a colon, just before the braketed sentence.\n",
        "                In your summary output you do NOT need to re-state this topic; but it should be kept in mind as a guide to what the unified theme of the entire block text being summarized, since the Topic will be the same for all sentences within a given text block given for summarization.\n",
        "                One important way to use this topic in your summarization is to help you tp determine the relevance of a given sentence to the overall summary. This is PARTICULARLY important for the text at the first and last pages (pages are also indicated for each sentence), because the text has not been perfectly parsed by the Topic, so some of the\n",
        "                text at the very beginnning and very end of the text to summarize may be from a different Topic than what the summary is intended to describe. So just be careful not to add into your summary\n",
        "                something that is from one of the first or last sentences of the text and is obviously unrelated to the Topic. In each case the Topic will be a semi-coded label for the text comes directly after it it, as follows: \"2B_Determination of Practice Expense RVUs: [from p. 12:[This is an example sentence]] 2B_Determination of Practice Expense RVUs: [from p. 13:[This is another example sentence]]\"\n",
        "                2B_Determination of Practice Expense RVUs: [from p. 12:[This is an example sentence]]\n",
        "                The output needs to sections, clearly delineated: 'Background', and 'Provision'.\n",
        "                Please do NOT use any 'meta' language, i.e., do NOT introduce what you are going to say by saying things like 'here you will find that the text discusses the concept of'[...]\n",
        "                 when you could instead say 'this section concerns' or something even  more succinct. Do NOT 'break the 4th wall' by making unnecessry references to the reader or you the writer; or otherwise re-state points already made: just jump into the summary.\n",
        "                Also, you don't need to fully spell out the words used in Acronyms more than once, and for three specific common acronyms (in this context) you NEVER need to fully spell out what the letters stand for, just give the 3-letter acronym: AMA (for American Medical Association), CMS (for Center for Medicare and Medicaid Services), and CY (for Contract Year).\n",
        "                Here is an example of what need for summary output. But be carefull NOT to use this actual content word for word, or to copy ideas out of this example that do not relate to the text which you are being asked to summarize.\n",
        "                It is VERY important to avoid superfluous words that do not add relevent information. Here are some examples of phrases that should be AVOIDED because of their burdonsome and irrelevant additions:\n",
        "                \"This extensive document outlines the methodology and updates related to the determination of Practice Expense (PE) Relative Value Units (RVUs) under the Medicare Physician Fee Schedule (PFS). Heres a concise summary:\",\n",
        "                \"This text is a detailed discourse on proposed changes and ongoing policies related to Medicare Telehealth Services.\", and so forth. In other words, do NOT comment on the source material except to summarize the text. It is very important that you stick to the structure described below and follow my instructions thoughtfully.\n",
        "                The example here is only meant to serve you as a STRUTCURAL and Linguistic STYLE example, but you DO need to use the terms 'Background' and 'Provision' exactly as below. Provision refers to the source material's larger document.:\n",
        "                Background:\n",
        "Practice Expense (PE) is the portion of resources used in furnishing a service that reflects the general categories of physician and practitioner expenses, such as office rent and personnel wages, but excluding malpractice (MP) expenses, as specified in section 1848(c)(1)(B) of the Act. PE RVUs are developed by considering the direct and indirect practice resources involved in furnishing each service. Direct expense categories include clinical labor, medical supplies, and medical equipment and are determined by adding the costs of the direct resources involved with furnishing that service. Indirect expenses include administrative labor, office expense, and all other expenses and are calculated using Physician Practice Expense Information Survey (PPIS) data that demonstrated the practice expenses incurred per hour worked. If a procedure can be done in a physician office and a facility setting, there are two PE RVUs: facility and non-facility. The CY 2010 PFS final rule, as well as the Calculations of PE RVUs under Methodology for Selected Codes file provides more detailed descriptions of the PE RVU methodology.\n",
        "The Medicare Economic Index (MEI) is an index that measures changes in the market price of inputs used to furnish physician services. Essentially, it is a measure that takes into account inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
        "\n",
        "Provision:\n",
        "CMS is proposing to NOT incorporate the finalized 2017-based MEI in PFS rate setting for CY 2024. This is due to AMAs intention to collect practice cost data from physician practices in the near future which could be used to derive cost share weights for the MEI and RVU shares, as well as the methodological and data source changes that could significantly impact PFS payments.\n",
        "                \"\"\"\n",
        "    return get_gpt4_summary(row['text'], prompt)\n",
        "\n",
        "# Apply summarization function to each row\n",
        "TEST_merged_df_Topic_text_combined['Topic Summary'] = summarize_topics(TEST_merged_df_Topic_text_combined)\n",
        "\n",
        "# Create final DataFrame\n",
        "Final_Topic_Summary_df_2 = TEST_merged_df_Topic_text_combined[['InsightsAI_Topic', 'Topic Summary', 'text']]\n",
        "\n",
        "\n",
        "\n",
        "Final_Topic_Summary_df_2\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "pzF2yd-iVGqw"
      },
      "outputs": [],
      "source": [
        "# Load your dataframe\n",
        "# Note: Ensure your dataframe is properly loaded into the variable `merged_df_Topic_text_combined`\n",
        "# merged_df_Topic_text_combined = pd.read_csv('your_dataframe.csv')\n",
        "import openai\n",
        "from transformers import GPT2TokenizerFast\n",
        "from IPython.display import HTML\n",
        "import pandas as pd\n",
        "\n",
        "#Rf the 33 rows, need to skip Row 17 because of it's size. So run first 16, then last 16\n",
        "#TEST_merged_df_Topic_text_combined=merged_df_Topic_text_combined\n",
        "\n",
        "# Setup OpenAI API key\n",
        "openai.api_key = \"your open AI key\"\n",
        "\n",
        "\n",
        "tokenizer = GPT2TokenizerFast.from_pretrained('Xenova/gpt-4')\n",
        "\n",
        "def num_tokens_from_string(text: str) -> int:\n",
        "    tokens = tokenizer.tokenize(text)\n",
        "    return len(tokens)\n",
        "\n",
        "def split_text_if_needed(text):\n",
        "    total_tokens = num_tokens_from_string(text)\n",
        "    if total_tokens <= 125000:\n",
        "        return [text]\n",
        "    else:\n",
        "        # Large text handling by splitting into chunks\n",
        "        tokens = tokenizer.tokenize(text)\n",
        "        # Aim to divide into parts with a reasonable maximum size\n",
        "        max_chunk_size = 120000  # set slightly lower than the max to account for prompt size\n",
        "        chunks = []\n",
        "        for i in range(0, len(tokens), max_chunk_size):\n",
        "            chunks.append(tokenizer.convert_tokens_to_string(tokens[i:i + max_chunk_size]))\n",
        "        return chunks\n",
        "\n",
        "def get_gpt4_summary(text_parts, prompt):\n",
        "    summaries = []\n",
        "    for part in text_parts:\n",
        "        input_text = f\"{part}\\n\\nPrompt: {prompt}\"\n",
        "        model_choice = \"gpt-4-turbo\" if num_tokens_from_string(input_text) > 7500 else \"gpt-4\"\n",
        "        response = openai.chat.completions.create(\n",
        "            model=model_choice,\n",
        "            messages=[{\"role\": \"user\", \"content\": input_text}],\n",
        "            max_tokens=600,\n",
        "            temperature=0.5,\n",
        "            n=1,\n",
        "        )\n",
        "        summarized_part = response.choices[0].message.content.strip()\n",
        "        summaries.append(summarized_part)\n",
        "    return \" \".join(summaries)\n",
        "\n",
        "def prepare_summary(row):\n",
        "    prompt = (\"\"\"This is a summarization task. The input text is several sentences retrieved from a very large reference document.\n",
        "                Make your whole summary 500 words or less. Make the final output a VERY concise but coherent analysis of the question,\n",
        "                and what the text says, picking up the themes and patterns in the overall text.The text to be summarized will come as a series of bracketed sentences. Each sentence starts with a semi-coded Topic label (it will have an alphnumeric code and then an English language text description) followed by a colon, just before the braketed sentence.\n",
        "                In your summary output you do NOT need to re-state this topic; but it should be kept in mind as a guide to what the unified theme of the entire block text being summarized, since the Topic will be the same for all sentences within a given text block given for summarization.\n",
        "                One important way to use this topic in your summarization is to help you tp determine the relevance of a given sentence to the overall summary. This is PARTICULARLY important for the text at the first and last pages (pages are also indicated for each sentence), because the text has not been perfectly parsed by the Topic, so some of the\n",
        "                text at the very beginnning and very end of the text to summarize may be from a different Topic than what the summary is intended to describe. So just be careful not to add into your summary\n",
        "                something that is from one of the first or last sentences of the text and is obviously unrelated to the Topic. In each case the Topic will be a semi-coded label for the text comes directly after it it, as follows: \"2B_Determination of Practice Expense RVUs: [from p. 12:[This is an example sentence]] 2B_Determination of Practice Expense RVUs: [from p. 13:[This is another example sentence]]\"\n",
        "                2B_Determination of Practice Expense RVUs: [from p. 12:[This is an example sentence]]\n",
        "                The output needs to sections, clearly delineated: 'Background', and 'Provision'.\n",
        "                Please do NOT use any 'meta' language, i.e., do NOT introduce what you are going to say by saying things like 'here you will find that the text discusses the concept of'[...]\n",
        "                 when you could instead say 'this section concerns' or something even  more succinct. Do NOT 'break the 4th wall' by making unnecessry references to the reader or you the writer; or otherwise re-state points already made: just jump into the summary.\n",
        "                Also, you don't need to fully spell out the words used in Acronyms more than once, and for three specific common acronyms (in this context) you NEVER need to fully spell out what the letters stand for, just give the 3-letter acronym: AMA (for American Medical Association), CMS (for Center for Medicare and Medicaid Services), and CY (for Contract Year).\n",
        "                Here is an example of what need for summary output. But be carefull NOT to use this actual content word for word, or to copy ideas out of this example that do not relate to the text which you are being asked to summarize.\n",
        "                It is VERY important to avoid superfluous words that do not add relevent information. Here are some examples of phrases that should be AVOIDED because of their burdonsome and irrelevant additions:\n",
        "                \"This extensive document outlines the methodology and updates related to the determination of Practice Expense (PE) Relative Value Units (RVUs) under the Medicare Physician Fee Schedule (PFS). Heres a concise summary:\",\n",
        "                \"This text is a detailed discourse on proposed changes and ongoing policies related to Medicare Telehealth Services.\", and so forth. In other words, do NOT comment on the source material except to summarize the text. It is very important that you stick to the structure described below and follow my instructions thoughtfully.\n",
        "                The example here is only meant to serve you as a STRUTCURAL and Linguistic STYLE example, but you DO need to use the terms 'Background' and 'Provision' exactly as below. Provision refers to the source material's larger document.:\n",
        "                Background:\n",
        "Practice Expense (PE) is the portion of resources used in furnishing a service that reflects the general categories of physician and practitioner expenses, such as office rent and personnel wages, but excluding malpractice (MP) expenses, as specified in section 1848(c)(1)(B) of the Act. PE RVUs are developed by considering the direct and indirect practice resources involved in furnishing each service. Direct expense categories include clinical labor, medical supplies, and medical equipment and are determined by adding the costs of the direct resources involved with furnishing that service. Indirect expenses include administrative labor, office expense, and all other expenses and are calculated using Physician Practice Expense Information Survey (PPIS) data that demonstrated the practice expenses incurred per hour worked. If a procedure can be done in a physician office and a facility setting, there are two PE RVUs: facility and non-facility. The CY 2010 PFS final rule, as well as the Calculations of PE RVUs under Methodology for Selected Codes file provides more detailed descriptions of the PE RVU methodology.\n",
        "The Medicare Economic Index (MEI) is an index that measures changes in the market price of inputs used to furnish physician services. Essentially, it is a measure that takes into account inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
        "\n",
        "Provision:\n",
        "CMS is proposing to NOT incorporate the finalized 2017-based MEI in PFS rate setting for CY 2024. This is due to AMAs intention to collect practice cost data from physician practices in the near future which could be used to derive cost share weights for the MEI and RVU shares, as well as the methodological and data source changes that could significantly impact PFS payments.\n",
        "              \"\"\")\n",
        "    text_parts = split_text_if_needed(row['text'])\n",
        "    return get_gpt4_summary(text_parts, prompt)\n",
        "\n",
        "# Application of the summarization function\n",
        "merged_df_Topic_text_combined['Topic_Summary'] = merged_df_Topic_text_combined.apply(prepare_summary, axis=1)\n",
        "\n",
        "# Output the DataFrame to an HTML file\n",
        "def generate_html_output(df):\n",
        "    html_content = '<html><head><style>body { font-family: Arial; } .summary { background: #f0f0f0; padding: 10px; margin-bottom: 10px; }</style></head><body>'\n",
        "    for index, row in df.iterrows():\n",
        "        html_content += f'<div class=\"summary\"><h3>Topic: {row[\"InsightsAI_Topic\"]}</h3><p>{row[\"Topic_Summary\"]}</p></div>'\n",
        "    html_content += '</body></html>'\n",
        "    return html_content\n",
        "\n",
        "html_output = generate_html_output(merged_df_Topic_text_combined)\n",
        "with open('output_summaries.html', 'w') as file:\n",
        "    file.write(html_output)\n",
        "\n",
        "merged_df_Topic_text_combined"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Optionally, display the DataFrame ans save as an html file:\n",
        "\n",
        "def generate_html_output(df):\n",
        "    html_content = '''\n",
        "    <style>\n",
        "        body {\n",
        "            font-family: \"Arial\", sans-serif;\n",
        "        }\n",
        "        .summary-container {\n",
        "            margin: 20px;\n",
        "            padding: 15px;\n",
        "            border-radius: 8px;\n",
        "            background-color: #f9f9f9;\n",
        "            box-shadow: 0 2px 4px rgba(0,0,0,0.1);\n",
        "        }\n",
        "        .topic-title {\n",
        "            color: #333;\n",
        "            font-size: 18px;\n",
        "        }\n",
        "        .summary-text {\n",
        "            color: #555;\n",
        "            font-size: 14px;\n",
        "            margin-top: 5px;\n",
        "        }\n",
        "    </style>\n",
        "    <div class=\"summary-container\">\n",
        "        <h2 style=\"color: #4B0082;\">Summary Overview</h2>'''\n",
        "\n",
        "    for _, row in df.iterrows():\n",
        "        html_content += f'''\n",
        "            <div>\n",
        "                <h3 class=\"topic-title\">Topic: {row[\"InsightsAI_Topic\"]}</h3>\n",
        "                <p class=\"summary-text\"><strong>Summary:</strong> {row[\"Topic_Summary\"]}</p>\n",
        "            </div>'''\n",
        "\n",
        "    html_content += '</div>'\n",
        "    return HTML(html_content)\n",
        "\n",
        "\n",
        "# Call the function to display HTML output\n",
        "html_output = generate_html_output(merged_df_Topic_text_combined)\n",
        "html_output"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "n-BxmBEVk1CC",
        "outputId": "fc03a269-920b-40cd-b155-bbe6b20c78dd"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <style>\n",
              "        body {\n",
              "            font-family: \"Arial\", sans-serif;\n",
              "        }\n",
              "        .summary-container {\n",
              "            margin: 20px;\n",
              "            padding: 15px;\n",
              "            border-radius: 8px;\n",
              "            background-color: #f9f9f9;\n",
              "            box-shadow: 0 2px 4px rgba(0,0,0,0.1);\n",
              "        }\n",
              "        .topic-title {\n",
              "            color: #333;\n",
              "            font-size: 18px;\n",
              "        }\n",
              "        .summary-text {\n",
              "            color: #555;\n",
              "            font-size: 14px;\n",
              "            margin-top: 5px;\n",
              "        }\n",
              "    </style>\n",
              "    <div class=\"summary-container\">\n",
              "        <h2 style=\"color: #4B0082;\">Summary Overview</h2>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2B_Determination of Practice Expense RVUs</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Practice Expense (PE) RVUs are calculated to reflect the expenses incurred in providing medical services, excluding malpractice costs. They are divided into direct and indirect costs. Direct costs consist of clinical labor, medical supplies, and equipment, calculated by summing the expenses associated with each service. Indirect costs include administrative labor and office expenses, derived from data like the Physician Practice Information Survey (PPIS) which informs on expenses per hour worked. The PE RVUs are adjusted for services provided in different settings (facility vs. non-facility) and have components for professional and technical services. The methodology for determining PE RVUs uses data from various sources including specific surveys for oncology and independent labs, and incorporates changes based on public comments and new data.\n",
              "\n",
              "Provision:\n",
              "CMS utilizes a resource-based system to determine PE RVUs, incorporating data from the PPIS and other surveys to update and refine the values. The transition to new PE RVUs uses a phased approach, considering impacts on payment rates across specialties. CMS continues to refine its methodology, responding to public feedback and updating inputs like clinical labor pricing to reflect current wage data. The ongoing updates aim to maintain payment accuracy and relativity among services. Despite the comprehensive data collection and methodological refinements, challenges such as data gaps and the need for periodic updates to reflect current practice costs remain prevalent.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2C_Potentially Misvalued Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Physician Fee Schedule (PFS) necessitates periodic reviews of Relative Value Units (RVUs) under the CMS guidelines to ensure accurate service valuation. Sections of the Act mandate the identification and adjustment of potentially misvalued services using specific criteria. This includes regular validation of RVUs for certain codes, considering factors like rapid growth, changes in practice expenses (PE), and the integration of new technologies. The American Medical Association (AMA) Resource-Based Relative Value Scale (RVS) Update Committee (RUC), MedPAC, and other stakeholders provide recommendations for RVU adjustments. The process also involves examining claims data, work time, and direct PE inputs from various data sources to inform valuation decisions.\n",
              "\n",
              "Provision:\n",
              "CMS actively identifies and reviews potentially misvalued codes as outlined in section 1848(c)(2)(K)(ii) of the Act. Categories for review include codes with fast growth, substantial changes in PE, and new technologies. The review process also considers codes frequently billed together, those with significant payment discrepancies across service sites, and those involving substantial changes in hospital stay durations or procedure times. CMS uses recommendations from the RUC and public comments to adjust RVUs. Additionally, CMS may conduct surveys and other data collection activities to support the valuation process. The public can nominate codes for review, which CMS evaluates to determine if they warrant revaluation under the PFS.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2D_Telehealth Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Medicare Telehealth Services under Section 1834(m) of the Act have evolved significantly, particularly highlighted by the changes during the COVID-19 Public Health Emergency (PHE). The list of Medicare Telehealth Services is updated through a regulatory process that categorizes services based on their similarity to existing services or their clinical benefits when delivered via telehealth. Temporary categories were added to accommodate services during the PHE, reflecting the necessity to adapt quickly to changing healthcare needs.\n",
              "\n",
              "Provision:\n",
              "CMS has proposed several adjustments and clarifications in response to the evolving landscape of telehealth services post-PHE. These include the continuation of certain telehealth flexibilities, the addition of new services to the Medicare Telehealth Services List on a temporary or permanent basis, and the extension of telehealth originating site facility fees. Furthermore, CMS has proposed to refine the process for reviewing and updating the Medicare Telehealth Services List to streamline the addition or removal of services and ensure clarity in the categorization and evaluation of telehealth services. This includes a more straightforward binary classification of services as either permanent or provisional, based on clinical equivalence or potential clinical benefits, to reduce confusion and enhance the efficiency of the review process.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2E_Valuation of Specific Codes</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The valuation of specific codes under the Physician Fee Schedule (PFS) involves a rigorous process to ensure accurate payment for medical services. This process includes the valuation of new, revised, and potentially misvalued codes. CMS collaborates with the Relative Value Scale Update Committee (RUC) and other stakeholders to gather recommendations and public comments, which are then considered in the rulemaking process. Regular updates and revisions reflect changes in medical practice and resource costs. The valuation process also addresses interim final values, accepting public comments post-publication to adjust payments in subsequent final rules.\n",
              "\n",
              "Provision:\n",
              "For CY 2024, CMS has proposed values for a wide range of services, including new and revised codes. The process now includes proposing values in the proposed rule, rather than establishing them as interim final in the final rule, to allow for broader input and refinement. Additionally, CMS has introduced a new process for valuing services furnished under specific conditions, such as telehealth and services provided by Community Health Workers, recognizing the evolving nature of healthcare delivery. This approach aims to enhance the accuracy and fairness of reimbursements, aligning them more closely with current clinical practices and resource utilization.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2F_E&M Visits</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Evaluation and Management (E/M) visits, critical to the Medicare Physician Fee Schedule (PFS), have been under review to better reflect current medical practices, reduce administrative burdens, and enhance payment accuracy. These visits account for about 40% of all PFS allowed charges, with office/outpatient (O/O) E/M visits constituting about half of these charges. The American Medical Association (AMA) and other stakeholders have been instrumental in revising E/M coding and payment structures. Changes include the elimination of history and physical exam as determinants for visit level, allowing billing based on medical decision making (MDM) or time spent. This shift aims to alleviate practitioner burnout and improve service valuation, addressing the complexity inherent in primary care and specialty non-procedural care. \n",
              "\n",
              "Provision:\n",
              "CMS has adopted several changes following extensive public input and collaboration with the AMA. These include the introduction of add-on codes for specific complexities in O/O E/M visits and a redefined payment structure effective from January 1, 2021. However, the implementation of a significant add-on code (G2211) addressing visit complexity has been delayed until 2024 due to a moratorium imposed by the Consolidated Appropriations Act, 2021. CMS continues to refine its policies on split (or shared) visits and other E/M services, aligning them with contemporary medical practice and ensuring that payment reflects the resources and complexity involved in different care settings. Moving forward, CMS is soliciting comments on the valuation of E/M services and considering alternative approaches to resource-based valuations, indicating ongoing efforts to adapt the PFS to evolving healthcare dynamics and needs.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2G_Geographic Practice Cost Indices</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Geographic Practice Cost Indices (GPCIs) is a measure developed by CMS to account for relative cost differences among localities compared to the national average for the three fee schedule components: work, practice expense (PE), and malpractice (MP). As per section 1848(e)(1)(E) of the Act, a 1.0 floor for the work GPCIs has been provided for services furnished from January 1, 2004, to January 1, 2024. The 1.0 work GPCI floor was extended through December 31, 2023, by the Consolidated Appropriations Act, 2021. In 2014, the Protecting Access to Medicare Act (PAMA) modified the fee schedule areas used for payment purposes in California, changing from the revised locality structure implemented in 1997 to Metropolitan Statistical Areas (MSAs) defined by the Office of Management and Budget (OMB).\n",
              "\n",
              "Provision:\n",
              "For calendar years 2022 through 2024, CMS proposes a new specification for visits other than critical care visits. The substantive portion would mean either one of the three key components (history, exam, or MDM) or more than half of the total time spent by the physician and NPP performing the split (or shared) visit. The CY 2024 work GPCIs and summarized GAFs do not reflect the 1.0 work floor. The CY 2024 GPCIs and summarized GAFs can be found on the CMS website. For payment purposes in California, a technical refinement is proposed to consolidate the number of distinct fee schedule areas from 32 to 29. This would involve identifying the Los Angeles-Long Beach-Anaheim MSA and the San Francisco-Oakland-Berkeley MSA by one unique locality number each, instead of the current two and three respectively.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2H_Payment for Skin Substitutes</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses the modification of the MSA (Metropolitan Statistical Area) names and locality numbers for San Francisco-Oakland-Berkeley and Los Angeles-Long Beach-Anaheim. It also considers Marin County's status as a transition area, which necessitates a unique locality number under section 1848(e)(6)(C) of the Act. The changes were intended to consolidate fee schedules areas that are no longer operationally necessary. However, due to timing constraints related to actions and coordination with various system maintainers, these changes could not be operationalized for CY 2023. Consequently, there were no changes to the existing locality numbers 05, 06, 08, 18, or 26 for CY 2023. The text also outlines objectives related to refining skin substitute policies under Medicare, which include ensuring a consistent payment approach across different settings and using a uniform benefit category for products, regardless of their composition. \n",
              "\n",
              "Provision:\n",
              "The text proposes various approaches to gather cost information for skin substitute products, such as reviewing market research, invoices, or cost information on Medicare claims. It also considers different billing approaches to account for the variability and resource costs of these products. One approach involves grouping the direct costs for skin substitute products based on the typically associated application procedure, similar to the high-cost/low-cost system used in the Outpatient Prospective Payment System (OPPS). Another approach involves creating separate procedure coding for specific product types. The text solicits comments on these potential methods to establish appropriate payment for skin substitute products under the PFS.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2I_Supervision of OP Therapy Svcs, KX Modifier, DSMT Svcs, and DSMT Telehealth</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses the supervision of outpatient therapy services, the application of the KX modifier, the provision of Diabetes Self-Management Training (DSMT) services by Registered Dietitians and Nutrition Professionals, and the integration of DSMT services via telehealth. It highlights changes in Medicare policies to accommodate remote therapeutic monitoring (RTM) under general supervision rather than direct supervision, which was previously required. This adjustment aims to facilitate remote monitoring by physical therapists (PTs) and occupational therapists (OTs) in private practice, enhancing access to these services. The discussion also includes the implementation of the KX modifier thresholds, which are adjusted annually based on the Medicare Economic Index (MEI) to reflect changes in economic conditions.\n",
              "\n",
              "Provision:\n",
              "The Centers for Medicare and Medicaid Services (CMS) are proposing regulatory changes to allow general supervision for RTM services provided by therapist assistants, a shift from the existing requirement for direct supervision by PTs and OTs in private practices. This proposal aligns with the broader CMS goal of expanding access to remote and telehealth services, reflecting adaptations to modern healthcare delivery methods. Additionally, CMS addresses the billing and supervision complexities in DSMT services delivered via telehealth, proposing that DSMT services can be billed by a certified provider even when delivered by other professionals within an accredited DSMT entity. This approach aims to maintain service quality while adapting to telehealth modalities. The proposed changes are part of ongoing efforts to update and streamline supervision and billing practices to better reflect current healthcare practices and technological advancements.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2J_Advancing Access to Behavioral Health Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Consolidated Appropriations Act of 2023 (CAA, 2023) introduces significant amendments to Medicare policies, focusing on enhancing access to behavioral health services. It includes statutory changes that expand Medicare coverage and payment for services provided by marriage and family therapists (MFTs) and mental health counselors (MHCs), recognizing their roles in treating mental health conditions outside hospital settings. The Act defines qualifications and service boundaries for MFTs and MHCs, aiming to integrate these professionals more fully into the behavioral health framework of Medicare Part B. Additionally, the Act addresses payment structures, such as specifying payment rates relative to those for psychologists and excluding certain services from consolidated billing requirements under skilled nursing facility systems.\n",
              "\n",
              "Provision:\n",
              "The proposed changes under the CAA, 2023, are aimed at revising existing Medicare policies to incorporate the expanded roles of MFTs and MHCs. This includes creating new billing codes, adjusting payment rates, and setting specific training and experience requirements for these professionals. The revisions also propose the use of telehealth for certain training aspects, reflecting a broader shift towards integrating digital health solutions in care provision. Moreover, the Act mandates educational outreach to familiarize providers with these new roles and billing practices. Collectively, these changes are intended to enhance the accessibility and quality of behavioral health services, addressing critical gaps in care and aligning Medicares behavioral health coverage with contemporary practice standards.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 2K_Medicare Parts A and B Payment for Dental Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Medicare Parts A and B generally exclude payment for dental services unless they are deemed inextricably linked to other covered medical services. Recent regulations and proposals have sought to identify specific clinical scenarios where dental services are crucial for the clinical success of certain medical treatments, particularly for patients undergoing treatments that induce immunosuppression, such as chemotherapy, or involve complex medical interventions like joint replacement surgeries and cardiovascular procedures. This is based on the understanding that untreated oral infections can lead to severe complications, affecting the overall success of the medical treatments.\n",
              "\n",
              "Provision:\n",
              "CMS has proposed amendments to the existing regulations to explicitly include scenarios where dental services should be covered due to their direct impact on the treatment of severe medical conditions. These include pre-treatment dental evaluations and necessary treatments to manage infections before initiating immunosuppressive therapies like chemotherapy and CAR T-cell therapy. The proposals also extend to dental services linked to the administration of bone-modifying agents where there's a risk of medication-related osteonecrosis of the jaw. Furthermore, CMS is exploring the extension of these provisions to cover dental services before cardiovascular interventions and other medical procedures where the risk of infection and its management are critical to the success of the primary treatment. The aim is to formalize the link between necessary dental treatments and their overarching impact on significant medical treatments, ensuring that these integrations are recognized and covered under Medicare Parts A and B. This approach reflects a broader understanding of the interdependencies between oral health and general medical care, emphasizing preventive care to enhance treatment outcomes and patient safety.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3A_Drugs and Biological Products Paid Under Part B </h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Medicare Part B covers a range of drugs and biological products, which includes those furnished incident to a physicians service, administered via durable medical equipment (DME), and others specified by statute. Payment for these products generally follows methodologies set by sections of the Act, primarily based on the average sales price (ASP) plus a percentage add-on. Recent legislative changes, including the Inflation Reduction Act (IRA), have introduced amendments affecting payment limits, beneficiary out-of-pocket costs, and introduced provisions for biosimilars.\n",
              "\n",
              "Provision:\n",
              "The IRA amendments include setting new payment limits for biosimilars when ASP data is unavailable, capping beneficiary coinsurance based on inflation-adjusted payment amounts, and modifying payment for insulin through DME by waiving deductibles and capping coinsurance. CMS seeks feedback on various aspects, from the addition of specialty codes for dentists to the coordination of benefits. Furthermore, CMS proposes regulatory updates to align with these legislative changes, ensuring that payment methodologies reflect the most current statutory requirements. These updates are crucial for maintaining compliance with federal mandates and ensuring that payment systems support beneficiary access to necessary treatments while controlling costs.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3B_RHCs and FQHCs</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) are critical components of the healthcare system, particularly for underserved rural and urban populations. These facilities provide a comprehensive range of services including medical, mental health, and preventive health services, often under challenging conditions with limited resources. Payment methodologies for RHCs and FQHCs have evolved over time, reflecting changes in healthcare policy and practice. RHCs generally receive an All-Inclusive Rate (AIR), while FQHCs transitioned to a Prospective Payment System (PPS) that adjusts rates based on geographic differences and specific service provisions. Recent legislative and regulatory updates have expanded the scope of services and the types of providers eligible for reimbursement under Medicare, reflecting a broader understanding of healthcare needs and a push towards more inclusive and comprehensive care models.\n",
              "\n",
              "Provision:\n",
              "Recent updates to Medicare policies under the Consolidated Appropriations Act (CAA), 2023 have introduced significant changes for RHCs and FQHCs. These include the extension of telehealth flexibilities post-Public Health Emergency (PHE), allowing for the continuation of remote mental health services and the use of audio-only communications in certain conditions. These provisions aim to maintain access to essential services without the need for in-person visits, reducing barriers for patients with limited technology access. Additionally, the inclusion of licensed marriage and family therapists and mental health counselors as billable practitioners starting January 1, 2024, aims to address the growing need for mental health services. The policy also supports the billing of new services such as Diabetes Self-Management Training (DSMT) and Medical Nutrition Therapy (MNT) as FQHC visits, further expanding the scope of care these centers can provide under Medicare. These changes are part of a broader effort to enhance the flexibility, reach, and comprehensiveness of services available to underserved populations, ensuring that RHCs and FQHCs can continue to meet the evolving health needs of their communities.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3C_RHCs and FQHCs Conditions for Certification or Coverage</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) are crucial in providing healthcare in underserved rural and urban areas. They offer a range of services under Medicare and Medicaid, facilitated by various healthcare professionals including nurse practitioners (NPs), physician assistants (PAs), clinical psychologists (CPs), clinical social workers (CSWs), and certified nurse midwives (CNMs). Recent legislative changes aim to further expand the scope of services provided by these facilities by including marriage and family therapists (MFTs) and mental health counselors (MHCs) as recognized staff members. The inclusion aims to enhance mental health support within these communities, acknowledging the unique and pressing healthcare needs of rural populations.\n",
              "\n",
              "Provision:\n",
              "The Consolidated Appropriations Act (CAA) 2023 mandates modifications to the Conditions for Certification or Coverage (CfCs) for RHCs and FQHCs to incorporate MFTs and MHCs into their service frameworks. This change aligns with the broader goal of addressing mental health care shortages in rural and underserved areas by broadening the range of professionals eligible to provide reimbursable services. Additionally, there are proposals to redefine the roles and qualifications of existing practitioners like NPs to reflect current certification standards and educational requirements, ensuring that staff qualifications remain relevant to the evolving healthcare landscape. These adjustments are intended to enhance the quality of care and ensure that the healthcare workforce is equipped to meet the diverse needs of the communities they serve.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3D_Clinical Lab Fee Schedule</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Clinical Laboratory Fee Schedule (CLFS) was established under Medicare to manage payment systems for clinical diagnostic laboratory tests (CDLTs). Before 2018, CDLTs were paid based on the lesser of the billed amount, the local fee schedule amount, or a national limitation amount. This system was updated with the Protecting Access to Medicare Act of 2014 (PAMA), which introduced a new payment methodology based on private payor rates. This change aimed to reflect more accurately the market rates for laboratory tests. Under the new system, the payment amount for each CDLT is determined by the weighted median of private payor rates, collected during specified data collection periods and reported in subsequent data reporting periods. The implementation of these changes began with a data collection in 2016, followed by the first reporting in 2017, affecting payments from 2018 onwards.\n",
              "\n",
              "Provision:\n",
              "The phase-in of payment reductions under PAMA was structured to limit reductions to no more than 10% per year from 2018 to 2020 and 15% per year from 2021 to 2023. However, subsequent legislative amendments under acts such as the Further Consolidated Appropriations Act, 2020, and the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) have adjusted these timelines and percentages. For instance, the CARES Act extended the phase-in period through 2024 and set specific reduction limits for subsequent years. Most recently, the Consolidated Appropriations Act of 2023 further extended the phase-in of payment reductions through 2026 and delayed the next data reporting period to January 2024. These legislative changes aim to provide a more gradual transition to the new payment system based on private payor rates, reflecting ongoing adjustments to the data reporting and collection schedules to accommodate various factors, including the impacts of the COVID-19 pandemic.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3E_Pulm/Cardiac/Intensive Cardiac Rehab Expansion of Supervising Practitioners</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Clinical Laboratory Fee Schedule (CLFS) payment rates for Clinical Diagnostic Laboratory Tests (CDLTs) are established based on information collected during specific data collection periods. For example, the rates for CY 2023 and CY 2024 were determined using data collected from January 1, 2016, through June 30, 2016. Similarly, the payment rates for CY 2025 through CY 2027 will be based on data collected from January 1, 2019, through June 30, 2019. The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) provided coverage of Cardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) under Medicare part B, and Pulmonary Rehabilitation (PR) under Medicare part B, effective from January 1, 2010. The Bipartisan Budget Act of 2018 (BBA of 2018) made statutory changes allowing specific practitioners to supervise these services from January 1, 2024.\n",
              "\n",
              "Provision:\n",
              "The BBA of 2018 permits the expansion of supervising practitioners for PR, CR, and ICR. The proposed revisions aim to codify these changes in the PR and CR/ICR regulations. The supervising practitioners can now include a physician assistant (PA), nurse practitioner (NP), or clinical nurse specialist (CNS). The settings must have a physician or NPP immediately available and accessible for medical consultations and emergencies at all times when items and services are being furnished under the programs. This expansion is intended to provide greater flexibility and access to these critical rehabilitation services. The proposed changes also include additions and revisions to language in  410.47 and 410.49 to align with these amendments. This includes adding a new term, nonphysician practitioner (NPP), and amending the term supervising physician to supervising practitioner, which now includes a physician or NPP.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3F_OUD OTP Coverage</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses the proposed amendments to  410.47 and 410.49, which pertain to the supervising practitioner standards for PR/CR/ICR programs under Medicare. The amendments aim to implement the changes to section 1861(eee) and (fff) of the Act as set forth in section 51008 of the BBA of 2018, expanding the types of practitioners that may supervise PR, CR, and ICR. The text also explores the new Medicare Part B benefit for Opioid Use Disorder (OUD) treatment services provided by Opioid Treatment Programs (OTPs) established by Section 2005 of the SUPPORT Act. This benefit covers OTPs' services during an episode of care from January 1, 2020.\n",
              "\n",
              "Provision:\n",
              "The proposed amendments to  410.47 and 410.49 aim to implement the provisions in the BBA of 2018 regarding the types of practitioners that may supervise PR, CR, and ICR starting January 1, 2024. Furthermore, CMS is proposing additional flexibilities for periodic assessments furnished via audio-only telecommunications by OTPs. This proposal aims to extend the audio-only flexibilities for periodic assessments furnished by OTPs through the end of CY 2024. The text also discusses the extension of telehealth flexibilities enacted in the Consolidated Appropriations Act of 2023, allowing certain mental health services to be furnished via telecommunications technology by physicians and other practitioners.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3G_MSSP</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Medicare Shared Savings Program (MSSP) aims to enhance care coordination, lower healthcare costs, and improve health outcomes by encouraging providers to form Accountable Care Organizations (ACOs). ACOs are groups of doctors, hospitals, and other healthcare providers who voluntarily come together to give coordinated high-quality care to their Medicare patients. The program operates under a model where participating ACOs can receive shared savings payments by meeting specific quality performance standards and demonstrating actual savings relative to a financial benchmark.\n",
              "\n",
              "Provision:\n",
              "The MSSP has undergone several regulatory adjustments to refine and improve its operations and effectiveness. CMS has proposed changes to the quality performance standards and reporting requirements, enhancing the flexibility and accuracy of patient assignment to ACOs, and revising financial benchmarks and risk adjustment models. These adjustments aim to encourage more providers to participate in the program, especially in underserved areas, by making the program's incentives and requirements clearer and more attainable. The proposed changes include the use of an expanded window for patient assignment, adjustments in the benchmarking methodology to accommodate regional and ACO-specific variations more equitably, and modifications to the risk adjustment model to better reflect the health status of assigned populations. These refinements are intended to support the sustainability of the MSSP, promote equity, and enhance the value-based care model that the program seeks to advance. Background:\n",
              "The Medicare Shared Savings Program (MSSP) has been evaluating various methodologies for calculating risk scores and benchmarks for Accountable Care Organizations (ACOs). This involves transitioning to the V28 CMS-HCC risk adjustment model, which has raised concerns about its impact on ACO financial performance, particularly for those serving high-risk populations. The current methodology shows a potential reduction in shared savings for ACOs with higher risk scores, prompting a proposal for an alternative approach to risk score calculation that could mitigate these adverse effects.\n",
              "\n",
              "Provision:\n",
              "The proposed modifications suggest recalculating both the performance year and benchmark year risk scores using the same CMS-HCC model applicable to the performance year, aiming to align the risk adjustment across all years of an ACO's agreement period. This change intends to provide a more accurate reflection of changes in patient severity and case mix, thereby enhancing the fairness and effectiveness of financial adjustments. Furthermore, CMS proposes to adjust the benchmark calculations to account for changes in the CMS-HCC risk adjustment methodology during the agreement period, ensuring consistency and reducing potential distortions in historical benchmarks. These adjustments are poised to improve the stability and predictability of ACO payments, encouraging sustained participation in the MSSP, especially by ACOs managing high-risk populations.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3H_Part B Payment Preventive Vaccine</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Medicare Part B covers preventive vaccines including pneumococcal, influenza, hepatitis B, and COVID-19, with specific conditions for hepatitis B vaccine administration based on risk. Payment for these vaccines and their administration does not require beneficiary coinsurance or the Part B deductible and is generally set at 95% of the Average Wholesale Price, except in specific settings where payment is based on reasonable cost. Other vaccines, like the zoster vaccine for shingles, are covered under Medicare Part D.\n",
              "\n",
              "Provision:\n",
              "CMS has standardized payment rates for the administration of pneumococcal, influenza, and hepatitis B vaccines at $30, independent of the Physician Fee Schedule (PFS). For COVID-19 vaccines, initially, a higher payment rate of $40 per dose was set during the pandemic, which will align with other vaccines at $30 post-pandemic. These rates are subject to annual updates based on the Medicare Economic Index (MEI) and adjusted for geographic cost differences. Additionally, CMS has introduced an in-home additional payment for vaccine administration under certain conditions, primarily to improve access for underserved and homebound populations. This includes a higher payment rate for COVID-19 vaccine administration in the home, which CMS proposes to extend to other vaccines while continuing to monitor utilization trends and potential abuse of this payment code.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3I_MDPP</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Medicare Diabetes Prevention Program (MDPP) is an expansion of the Diabetes Prevention Program (DPP), initially tested by CMS through a Health Care Innovation Award. MDPP was established in 2017 as a covered preventive service under Medicare, aiming to prevent or delay the onset of type 2 diabetes among eligible Medicare beneficiaries diagnosed with prediabetes. The program involves no fewer than 22 sessions over 12 months, utilizing a CDC-approved curriculum to educate on dietary changes, increased physical activity, and behavior change strategies for weight control and diabetes risk reduction. MDPP suppliers are required to enroll in Medicare and are subject to a national quality assurance program managed by the CDC.\n",
              "\n",
              "Provision:\n",
              "CMS has proposed several amendments to the MDPP regulations to enhance the delivery and effectiveness of the program. These include redefining and removing certain terms and definitions to simplify the regulations and introducing new payment structures to incentivize supplier performance and streamline claims processing. Notably, the proposed changes include extending COVID-19 public health emergency flexibilities, such as permitting virtual delivery of services and alternative methods for beneficiary weight measurements, for an additional four years. Additionally, CMS aims to revise the payment model from performance-based to a hybrid model that includes fee-for-service payments for session attendance and performance payments for achieving weight loss goals. These changes are intended to increase the accessibility of MDPP, reduce administrative burdens on suppliers, and potentially increase beneficiary participation and retention by making the program more adaptable to suppliers' and participants' needs.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3J_Appropriate Use Criteria for Advanced Diagnostic Imaging</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Appropriate Use Criteria (AUC) program, established by CMS under the Protecting Access to Medicare Act (PAMA), aims to enhance the use of evidence-based guidelines in selecting advanced diagnostic imaging services like CT, PET, MRI, and nuclear medicine. The program mandates that clinicians consult AUC through qualified Clinical Decision Support Mechanisms (CDSMs) before ordering these services. The primary goal is to ensure that imaging services are appropriate for the patient's specific clinical condition, thereby improving health outcomes and reducing unnecessary testing.\n",
              "\n",
              "Provision:\n",
              "CMS has implemented the AUC program in phases, starting with defining Provider-Led Entities (PLEs) and CDSMs, and moving towards full implementation where compliance affects payment. However, the program has faced significant challenges, particularly with the real-time claims-based reporting requirement. This requirement has proven difficult to operationalize due to the limitations of the Medicare claims processing system. As such, CMS has proposed to pause the AUC program to reevaluate its feasibility and effectiveness. During this pause, CMS intends to rescind current regulations and cease the educational and operations testing period, recognizing the complexity and potential for inappropriate claim denials. Despite this pause, CMS continues to acknowledge the value of clinical decision support tools and encourages their voluntary use to improve the quality and efficiency of patient care.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3K_Medicaid Provider Enrollment</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The text discusses the intricacies and regulations surrounding Medicaid and Medicare provider enrollment, emphasizing the need for compliance with federal and state requirements to safeguard against fraud and ensure service quality. It highlights the various processes and criteria for enrolling providers, the importance of accurate and timely information submission, and the consequences of non-compliance, including revocation and denial of enrollment. Key aspects such as the roles of authorized and delegated officials, the impact of ownership interests, and the specifics of reporting changes in practice locations are covered to ensure clarity and compliance in provider enrollment practices.\n",
              "\n",
              "Provision:\n",
              "The provisions address the need for stringent measures in the enrollment and revalidation of providers in Medicaid and Medicare programs. They propose revisions to enhance the clarity and efficiency of the enrollment process, including defining terms like \"indirect ownership\" and \"authorized officials\" to prevent ambiguities. The text also suggests modifications to current policies to streamline processes and tighten security, such as specifying the duration for which a provider's termination remains active in databases and the conditions under which states must deny or terminate a provider's enrollment. These changes aim to fortify the integrity of Medicaid and Medicare programs, ensuring that only qualified and compliant providers are allowed to participate.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3L_Expand Diabetes Screening and Diabetes Definitions</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Diabetes is a chronic disease that affects how the body processes blood glucose. There are three main types: Type 1, Type 2, and gestational diabetes. Approximately 37.3 million Americans have diabetes, with an additional 96 million having prediabetes. Diabetes screening is crucial as it helps in early detection and management of the condition, potentially improving health outcomes by preventing or delaying complications such as kidney failure, blindness, and cardiovascular diseases.\n",
              "\n",
              "Provision:\n",
              "The Medicare program under Part B covers diabetes screening tests, including the Fasting Plasma Glucose (FPG) test, the Glucose Tolerance Test (GTT), and the HbA1c test, which has been recently added. These tests are covered twice per calendar year for individuals with prediabetes and once for those without or never tested before. The screening is aimed at individuals at risk due to factors like obesity or a family history of diabetes. Additionally, Medicare provides Medical Nutrition Therapy (MNT) and Diabetes Self-Management Training (DSMT) services, which are crucial for managing diabetes effectively.\n",
              "\n",
              "Recent proposals aim to simplify the regulatory definitions of \"diabetes\" across these services by removing specific clinical test requirements from the definitions, thus allowing for greater flexibility and adaptability to evolving clinical standards. This change is intended to streamline processes and reduce regulatory burdens, facilitating easier access to necessary services without compromising the quality of care or oversight.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3M_EPCS Part D</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The CMS Electronic Prescribing for Controlled Substances (EPCS) Program, mandated by the SUPPORT Act, requires Part D prescribers to electronically prescribe controlled substances. This initiative aims to enhance prescription security, reduce fraud, and ensure compliance through electronic systems. The program stipulates a compliance threshold where prescribers must electronically issue at least 70% of their Schedule II-V controlled substances prescriptions. Various rules and modifications have been adopted over the years to refine this mandate, including adjustments to compliance actions and the introduction of exceptions for recognized emergencies or extraordinary circumstances.\n",
              "\n",
              "Provision:\n",
              "The CMS EPCS Program has undergone several updates to improve its implementation and compliance monitoring. Key provisions include the adoption of specific electronic prescribing standards, such as the NCPDP SCRIPT standard, and adjustments to the compliance threshold calculation to consider unique prescriptions rather than total fills. Exceptions for recognized emergencies and extraordinary circumstances have been refined, allowing for more targeted applications and adjustments during specific events like natural disasters or public health emergencies. The program also outlines a process for prescribers to request waivers under extraordinary circumstances, with a defined timeframe for application following a non-compliance notification. These measures aim to streamline the EPCS process, align it with other CMS quality programs, and ensure that prescribers can meet the requirements without undue burden.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3N_Ambulance Fee and GADCS</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Medicare Ground Ambulance Data Collection System (GADCS) was established to gather comprehensive data on cost, revenue, utilization, and other relevant metrics from ground ambulance providers and suppliers. This initiative, mandated by section 1834(l) of the Act, aims to enhance transparency and efficiency in ambulance service provision by requiring detailed reporting. The system, which includes a data collection instrument and a web-based portal, was developed to facilitate this data submission, with specific provisions for different types of ambulance services including those based in rural areas or associated with public safety departments.\n",
              "\n",
              "Provision:\n",
              "CMS has implemented several updates to the GADCS to improve data quality and reduce the reporting burden on providers. These updates include modifications to the data collection instrument to clarify existing questions and add new response options to better capture operational specifics, such as partial-year operations. Furthermore, CMS has addressed programming logic issues to ensure that the data collection instrument accurately reflects the diverse operational models of ambulance services, particularly distinguishing between those with responsibilities in public safety and those without. These revisions are intended to streamline the data submission process, enhance the accuracy of the data collected, and ultimately inform CMSs policy decisions regarding ambulance services. CMS continues to solicit feedback on these changes and makes adjustments as needed to support the goals of the GADCS.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3O_Hospice: Changes to Conditions of Participation</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "Hospice care, a service offered to terminally ill Medicare beneficiaries, is regulated by the Conditions of Participation (CoPs) established by the Secretary under section 1861(dd)(2)(G) of the Act. These conditions, set forth at 42 CFR part 418, apply to the hospice as an entity and to the services furnished to each individual under hospice care, ensuring the health and safety of individuals. The Consolidated Appropriations Act of 2023 (CAA 2023) introduced a new Medicare benefit category for marriage and family therapist (MFT) services and mental health counselor (MHC) services, adding these services to covered hospice care services. Consequently, the hospice CoPs at  418.56 and 418.114 are proposed to be modified to allow MHCs or MFTs to serve as members of the interdisciplinary group (IDG).\n",
              "\n",
              "Provision:\n",
              "The proposed regulations aim to update the Hospice CoPs to permit Mental Health Counselors or Marriage and Family Therapists to serve as members of the Hospice Interdisciplinary Group. This is in accordance with the CAA 2023, which established a new Medicare benefit category for MFT and MHC services. Therefore, the IDG must include a social worker (SW), an MFT, or an MHC. The regulations also propose to add MHC and MFT to the personnel qualifications at  418.114, and to the provider requirements under 42 CFR subpart B, Medical and Other Health Services at  410.54 and 410.53. The proposed changes emphasize the importance of assessing and determining the care and services that best align with the preferences and needs of the patient. The roles of SW, MFT, and MHC vary greatly, each offering unique support and services to the patient and family. The proposed changes invite comments on these proposals related to GADCS typos and technical corrections.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3P_Solicitation: Histopathology, Cytology, and Clinical Cytogenetics Regs under CLIA</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Clinical Laboratory Improvement Amendments (CLIA) of 1988 and subsequent updates have established regulations for various laboratory procedures, including histopathology, cytology, and clinical cytogenetics. These regulations ensure that laboratory practices meet specific standards to maintain accuracy and reliability in testing. Histopathology involves the microscopic examination of tissue to diagnose diseases, and the process includes steps like slide preparation, staining, and gross tissue examination. Cytology involves examining cells from various body sites to detect disease, and clinical cytogenetics involves analyzing chromosomal changes related to genetic diseases.\n",
              "\n",
              "Provision:\n",
              "The recent discussions under CLIA regulations have emphasized the need to update several aspects of these laboratory procedures. For histopathology, there is a focus on potentially enhancing oversight of tissue sample preparation and staining, particularly addressing both routine and complex immunohistochemical (IHC) staining processes. The qualifications for personnel performing these high-complexity tasks are under review, with considerations for specific training and experience requirements. In cytology, the regulations reinforce that slide preparations must be evaluated within the premises of a certified laboratory. During the COVID-19 public health emergency, temporary measures allowed pathologists to review slides remotely, a practice which some parties wish to continue post-emergency. Clinical cytogenetics has been highlighted for its high complexity, with discussions on whether certain distributive testing models should be officially recognized, allowing parts of the testing process to be conducted at different sites without each needing separate CLIA certification, provided they meet certain conditions. These discussions may lead to regulatory changes to adapt to technological advances and evolving needs in laboratory medicine.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3Q_Changes to the Basic Health Program Regulations</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Basic Health Program (BHP) under the Affordable Care Act provides states with the option to offer affordable health coverage to low-income individuals who do not qualify for Medicaid. The program is designed to ensure that individuals with incomes between 133% and 200% of the Federal Poverty Level have access to affordable health insurance. States like New York and Minnesota have already implemented BHPs, which are funded by 95% of the premium tax credits and cost-sharing reductions that enrollees would have received through the Health Insurance Exchanges. The BHP funding is used exclusively to reduce premiums, cost-sharing, or to enhance benefits for eligible individuals.\n",
              "\n",
              "Provision:\n",
              "The proposed changes to the BHP regulations allow states to temporarily suspend their BHP to explore alternative ways of providing coverage without increasing federal costs. This suspension can be for up to five years, with a possible extension of another five years. During the suspension, the state must ensure that the alternative coverage is at least as comprehensive and affordable as the BHP. The state must also continue to meet all federal requirements and provide detailed reports on the alternative coverage's performance. If a state decides to resume the BHP after suspension, it can use the funds accrued in the BHP trust fund to restart the program. Additionally, any interest accrued on the BHP trust fund during the suspension must be remitted to the federal government. This proposal aims to offer states flexibility in managing their health coverage programs while maintaining oversight to ensure that the coverage provided meets federal standards and effectively serves eligible individuals.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3R_Updates to the Definitions of CEHRT</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The American Recovery and Reinvestment Act of 2009 authorized incentive payments to promote the adoption and meaningful use of Certified Electronic Health Record Technology (CEHRT). The Office of the National Coordinator for Health Information Technology (ONC) launched the Health IT Certification Program in 2010 to certify health IT, including EHRs. The program supports the use of certified health IT under various programs such as the Medicare Promoting Interoperability Program, the Shared Savings Program, and the Quality Payment Program. For 2019 and subsequent years, the definitions of CEHRT require the use of EHR technology that meets the 2015 Edition Base EHR definition and is certified under the ONC Health IT Certification Program. However, the use of certified health IT has expanded to other government and non-government programs.\n",
              "\n",
              "Provision:\n",
              "The ONC has proposed to discontinue the year-themed editions, to distinguish between sets of health IT certification criteria finalized in different rules. Instead, it proposes a single set of certification criteria, updated incrementally in alignment with standards development cycles and regular health IT development timelines. The proposed revisions to the CEHRT definitions in the Medicare Promoting Interoperability Program and the Quality Payment Program aim to support the transition from the historical state of year-themed editions to the edition-less state. These revisions would allow the CEHRT definitions to automatically incorporate ONCs updates to relevant certification criteria without pursuing additional rulemaking. However, CMS will continue to determine when new or revised versions of measures that require the use of certified health IT would be required for participation under these programs.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 3S_SDOH Risk Assessment in the AWV</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Social Determinants of Health (SDOH) Risk Assessment is proposed to be an optional, additional element in the Annual Wellness Visit (AWV) under Medicare Part B, enhancing patient-centered care by addressing non-medical factors that impact health. SDOH refers to environmental conditions such as economic stability, education access, healthcare access, neighborhood environments, and social context that influence individual health outcomes. Recognizing that 50% of health outcomes are determined by SDOH, CMS aims to integrate a structured assessment to better address these factors, thus promoting health equity and improving care management. This initiative builds on previous models like the Accountable Health Communities (AHC) Model and incorporates public feedback on the existing AWV structure.\n",
              "\n",
              "Provision:\n",
              "CMS proposes to revise the AWV to include an optional SDOH Risk Assessment with additional payment, aiming to provide a more comprehensive health evaluation that considers SDOH factors. This assessment is intended to be standardized, evidence-based, culturally sensitive, and furnished without beneficiary cost-sharing when performed alongside the AWV. The proposed changes are designed to empower healthcare providers to address SDOH effectively, thereby enhancing the overall care and prevention strategies offered to Medicare beneficiaries. Furthermore, CMS suggests regulatory modifications to facilitate the adoption of this assessment, emphasizing its potential to reduce healthcare disparities and improve outcomes for underserved populations. Public comments are invited to refine this proposal, ensuring it meets the needs of both providers and beneficiaries effectively.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7D_Changes Related to Telehealth Services</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background: \n",
              "The proposed changes to Telehealth Services are a part of the provisions of the CAA, 2023 that amended section 1834(m) of the Act. These changes are set to extend certain Medicare telehealth flexibilities till December 31, 2024. The changes include allowing Medicare telehealth services to be provided to patients located anywhere within the U.S., expanding the scope of telehealth practitioners to include occupational therapists, physical therapists, speech-language pathologists, and audiologists. It also includes the extension of payment for telehealth services furnished by FQHCs and RHCs and a delay in the requirement of an in-person visit with the physician or practitioner within 6 months before an initial mental health telehealth service. \n",
              "\n",
              "Provision:\n",
              "In the proposed rule, a refined process for considering requests for adding services to the Medicare Telehealth Services List is being proposed. The decision on whether the services should be included on the list will be made on either a permanent or provisional basis. However, the underlying criteria for adding services to the list are not changing, and this proposal is not expected to impact the utilization of Medicare Telehealth services beginning in CY 2024. From CY 2024, claims billed with POS 10 (Telehealth Provided in Patient's Home) will be paid at the non-facility PFS rate. Claims billed with POS 02 (Telehealth Provided Other than in Patients Home) will continue to be paid at the PFS facility rate. The impact of this proposal is expected to be neutral, assuming that utilization remains at current levels for these services. It is anticipated that these provisions will result in continued utilization of Medicare telehealth services during CY 2024 at levels comparable to observed utilization of these services during the PHE for COVID19.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7E_Other Provisions in the Regulation</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The Medicare Shared Savings Program (MSSP) facilitates collaboration among healthcare providers to improve the quality of care and reduce costs. This program involves Accountable Care Organizations (ACOs) that agree to be accountable for the quality, cost, and overall care of Medicare beneficiaries. The program's payment models encourage ACOs to invest in care coordination and health care innovation to improve outcomes and achieve cost savings, which can result in shared savings with CMS.\n",
              "\n",
              "Provision:\n",
              "CMS is proposing changes to enhance the Medicare Shared Savings Program. These changes aim to increase ACO participation, especially in underserved areas, by offering new entrants the choice of a more gradual progression to performance-based risk. The adjustments include modifications to benchmarking methods, which involve a blend of regional and national spending data to set more equitable and competitive targets for ACOs. Additionally, the proposal includes updates to the risk adjustment model to better reflect the health status of assigned beneficiaries. The proposed rule also suggests simplifying the program's operational aspects to reduce administrative burdens for ACOs, potentially leading to greater participation and retention in the program. Furthermore, CMS anticipates these changes to contribute positively to the program's goals of enhancing care quality and reducing healthcare costs.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7F_Alternatives Considered</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background: \n",
              "The proposed rule discusses changes in the regulatory definitions of Certified Electronic Health Record Technology (CEHRT), Electronic Health Record (EHR) requirements, and assumptions and limitations in data usage. The text highlights potential impacts on clinicians and Medicare revenues due to variations in clinicians' final scores and changes in data submission. It also acknowledges the challenges in predicting clinicians' decisions to participate in the Merit-based Incentive Payment System (MIPS). The document further explores the potential impacts of the proposed policies on Physician Fee Schedule (PFS) services, the Office/Outpatient (O/O) E/M visit inherent complexity add-on separate payment, and provider enrollment provisions. \n",
              "\n",
              "Provision: \n",
              "The proposed rule contains a range of policies, including those related to statutory provisions. It considers alternatives to the current policy for the O/O E/M visit inherent complexity add-on code, which could result in an estimated impact on the Conversion Factor (CF) of -3.2 percent. The proposal aims to improve payment accuracy for resource costs inherent to primary care and other medical care services in the office setting. No alternatives were considered for the Medicare Diabetes Prevention Program (MDPP) due to the normalization of synchronous virtual delivery of healthcare services during the COVID-19 public health emergency. The proposed rule also discusses the impact of the Quality Payment Program, specifically the performance threshold as a critical factor affecting the distribution of payment adjustments. The document concludes with an analysis of the impact on beneficiaries, particularly regarding the Medicare Shared Savings Program provisions.</p>\n",
              "            </div>\n",
              "            <div>\n",
              "                <h3 class=\"topic-title\">Topic: 7_Regulatory Impact Analysis</h3>\n",
              "                <p class=\"summary-text\"><strong>Summary:</strong> Background:\n",
              "The proposed rule by CMS introduces multiple regulatory changes aimed at updating payment systems and policies under Medicare, addressing statutory changes from recent legislative acts, and refining various Medicare programs. These updates include adjustments to the Physician Fee Schedule (PFS) and modifications to the Medicare Shared Savings Program, among others. The rule also proposes changes to address the needs of specific patient populations, such as those with opioid use disorder, and implements new provisions for telehealth services, reflecting ongoing shifts in healthcare practice and policy needs.\n",
              "\n",
              "Provision:\n",
              "CMS has submitted the proposed rule for review, which includes potential information collection requirements that will not be effective until approved. The public is invited to comment on these requirements. The proposed changes aim to ensure the Medicare program's sustainability and adaptability to current medical practice and technology advancements. This includes updates to payment policies under Medicare Part B, adjustments to the Quality Payment Program, and enhancements to provider enrollment policies. The rule also outlines specific statutory provisions, such as extending telehealth flexibilities and adjusting payment models for certain drugs under Medicare Part B, to align with recent legislative changes.</p>\n",
              "            </div></div>"
            ]
          },
          "metadata": {},
          "execution_count": 53
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "merged_df_Topic_text_combined"
      ],
      "metadata": {
        "id": "rzqG7QfJj4yv"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 201
        },
        "id": "jzrEfIfB7juJ",
        "outputId": "3599a0c5-7e5a-4a22-f990-78e03a7f8fd0"
      },
      "outputs": [
        {
          "ename": "NameError",
          "evalue": "name 'comment' is not defined",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-84-8e4c5fae1811>\u001b[0m in \u001b[0;36m<cell line: 49>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     47\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     48\u001b[0m \u001b[0;31m# Test the function using your comment\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 49\u001b[0;31m \u001b[0mfinal_out\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mgenerateRulesSummary\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtext\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcomment\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     50\u001b[0m \u001b[0mfinal_out\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mNameError\u001b[0m: name 'comment' is not defined"
          ]
        }
      ],
      "source": [
        "# MODULE 7A\n",
        "# Generate and present the final summary output in HTML format\n",
        "#!pip install openai\n",
        "#!pip install tiktoken\n",
        "from IPython.display import HTML\n",
        "import openai\n",
        "import tiktoken\n",
        "\n",
        "\n",
        "comment=\"What does this document say about Payment for Medicare Dental Services?\"\n",
        "def generateRulesSummary(text, comment):\n",
        "\n",
        "    openai.api_key = \"your open AI key\"\n",
        "\n",
        "    def num_tokens_from_string(string: str, encoding_name: str) -> int:\n",
        "        encoding = tiktoken.encoding_for_model(encoding_name)\n",
        "        num_tokens = len(encoding.encode(string))\n",
        "        return num_tokens\n",
        "\n",
        "    def get_gpt4_summary(text, prompt=\"\"):\n",
        "        input_text = f\"{text}\\n\\nPrompt: {prompt}\"\n",
        "        Char_length = len(input_text)\n",
        "        model_choice = \"gpt-4-turbo\" if num_tokens_from_string(input_text, \"gpt-4\") > 8192 else \"gpt-4\"\n",
        "        response = openai.chat.completions.create(\n",
        "            model=model_choice,\n",
        "            messages=[{\"role\": \"user\", \"content\": input_text}],\n",
        "            max_tokens=600,\n",
        "            temperature=0.5,\n",
        "            n=1,\n",
        "        )\n",
        "        generated_summary = response.choices[0].message.content.strip()\n",
        "        return generated_summary\n",
        "\n",
        "    TopicSummary = get_gpt4_summary(text, f\"\"\"This is a summarization task. The input text provided here is in two parts: first part is labeled 'COMMENT' and the second is a set of several sentences retreived from a very large reference document. The first part, the COMMENT, is a response to the entire reference document from which the second part was extracted. This comment (reponse to the reference document) is clearly bracketed. PLease write a summary that briefly restates this comment in brackets first, then goes on to summarize the various sentences from the reference document. Make your whole summary 150 words or less. Make the final output a concise but coherent analysis of the comment (15-25 words), and then ending with what the reference sentences say in relation to the comment (125-140 words).\n",
        "  You should have the following format for the output: [here you will place the VERY brief summary of the comment, again: about 15-25 words, NO MORE. THe narrative of your summarization should refer to the 'COMMENT' as the Major Commentor (MC) comment in your first reference, and then MC comment after that. The second part of your response follows. Then you will complete your response with the text for the rest of the summary: first, the following header: \"RELEVANT TEXT from PROPOSED RULE (CMS-2023-0121-0001):\", then finish with the rest of the summary. The balance of your output after the first part will explain why these sentences from the reference document (refered to as the \"Regulations Propsoal\") are relevant to the MC comment. Also, BE SURE TO INCLUDE THE REGULATIONS PAGE NUMBER for any material referenced from the text. These page numbers must be HIGHLY ACCURATE, so that whatever is said to be discussed on that page is actually on that page. (Be VERY careful to compare the text to the page number.) THe page number infomration is given for each sentence, so you will be able to be sure. It will be noted in each input sentence you are given.\"\"\")\n",
        "\n",
        "    # Generate the HTML format for the final output\n",
        "    html_output = f'''\n",
        "    <div style=\"font-family: Arial, sans-serif;\">\n",
        "        <h2>Comment from Major Commentor on Sub-Topic 2B5</h2>\n",
        "        <p><strong>Summary of relevant text from PROPOSED RULE (CMS-2023-0121-0001)</strong></p>\n",
        "        <p>{TopicSummary}</p>\n",
        "        <p><strong>Complete Comment:</strong></p>\n",
        "        <p><i>{comment}</i></p>\n",
        "    </div>\n",
        "    '''\n",
        "\n",
        "    #return HTML(html_output)\n",
        "\n",
        "# Test the function using your comment\n",
        "final_out = generateRulesSummary(text, comment)\n",
        "final_out"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 206
        },
        "id": "UhsUZlQrQTRA",
        "outputId": "3dd52b37-8d79-4ca2-9793-5d8b40b09415"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"merged_df\",\n  \"rows\": 18848,\n  \"fields\": [\n    {\n      \"column\": \"text\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 18698,\n        \"samples\": [\n          \"Topic: 2K_Medicare Parts A and B Payment for Dental Services323: [from p. 323: [Moreover, the \\nimmunosuppression induced by the chemotherapy medical services in the treatment of cancer \\nincreases the likelihood and intensity of complications for the patient that could potentially \\njeopardize or impact the ability to complete the totality of the treatment across a normal course \\nof treatment.]]\",\n          \"Topic: 7F_Alternatives Considered1830: [from p. 1830: [These revisions take the measure one step further to ensure actions are being \\ntaken once the screening is completed so patients receive the appropriate care resulting in positive health outcomes.]]\",\n          \"Topic: 7F_Alternatives Considered1593: [from p. 1593: [The \\ninclusion of both \\nquality measures in \\nthis specialty set \\nwould be \\nduplicative.]]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"InsightsAI_Topic\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 33,\n        \"samples\": [\n          \"7E_Other Provisions in the Regulation\",\n          \"3F_OUD OTP Coverage\",\n          \"3Q_Changes to the Basic Health Program Regulations\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "merged_df"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-de020079-9680-4446-8319-16a07644c224\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>text</th>\n",
              "      <th>InsightsAI_Topic</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>140</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>141</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>142</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>143</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>144</th>\n",
              "      <td>Topic: 2B_Determination of Practice Expense RV...</td>\n",
              "      <td>2B_Determination of Practice Expense RVUs</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-de020079-9680-4446-8319-16a07644c224')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-de020079-9680-4446-8319-16a07644c224 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-de020079-9680-4446-8319-16a07644c224');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-fe6c3c8f-01e7-4ca9-b998-94a9dd501a92\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-fe6c3c8f-01e7-4ca9-b998-94a9dd501a92')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-fe6c3c8f-01e7-4ca9-b998-94a9dd501a92 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                                                  text  \\\n",
              "140  Topic: 2B_Determination of Practice Expense RV...   \n",
              "141  Topic: 2B_Determination of Practice Expense RV...   \n",
              "142  Topic: 2B_Determination of Practice Expense RV...   \n",
              "143  Topic: 2B_Determination of Practice Expense RV...   \n",
              "144  Topic: 2B_Determination of Practice Expense RV...   \n",
              "\n",
              "                              InsightsAI_Topic  \n",
              "140  2B_Determination of Practice Expense RVUs  \n",
              "141  2B_Determination of Practice Expense RVUs  \n",
              "142  2B_Determination of Practice Expense RVUs  \n",
              "143  2B_Determination of Practice Expense RVUs  \n",
              "144  2B_Determination of Practice Expense RVUs  "
            ]
          },
          "execution_count": 63,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "merged_df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "wC3KnJssDsy9"
      },
      "outputs": [],
      "source": [
        "#Module 6b (alternate approach: read data frame and iterate on each input text, writing out a data frame.)\n",
        "#!pip install openai --upgrade\n",
        "from IPython.display import HTML\n",
        "\n",
        "TEST_merged_df_Topic_text_combined=merged_df_Topic_text_combined\n",
        "\n",
        "\n",
        "# Setup OpenAI API key\n",
        "openai.api_key = \"your open AI key\"\n",
        "\n",
        "# MODULE 7B - ALT Summary as Topic Data Frame\n",
        "# Generate and present the final summary output in HTML format\n",
        "#!pip install openai\n",
        "#!pip install tiktoken\n",
        "import pandas as pd\n",
        "import openai\n",
        "from IPython.display import HTML\n",
        "\n",
        "def num_tokens_from_string(string: str, encoding_name: str='gpt-4') -> int:\n",
        "    # Simulating encoding length function, adjust as needed\n",
        "    return len(string)\n",
        "\n",
        "def get_gpt4_summary(text, prompt=\"\"):\n",
        "        input_text = f\"{text}\\n\\nPrompt: {prompt}\"\n",
        "        Char_length = len(input_text)\n",
        "        model_choice = \"gpt-4-turbo-preview\" if num_tokens_from_string(input_text, \"gpt-4\") > 8192 else \"gpt-4\"\n",
        "        response = openai.chat.completions.create(\n",
        "            model=model_choice,\n",
        "            messages=[{\"role\": \"user\", \"content\": input_text}],\n",
        "            max_tokens=600,\n",
        "            temperature=0.5,\n",
        "            n=1,\n",
        "        )\n",
        "        generated_summary = response.choices[0].message.content.strip()\n",
        "        return generated_summary\n",
        "\n",
        "def summarize_topics(row):\n",
        "    prompt = \"\"\"This is a summarization task. The input text is several sentences retrieved from a very large reference document.\n",
        "                Make your whole summary 500 words or less. Make the final output a VERY concise but coherent analysis of the question,\n",
        "                and what the text says, picking up the themes and patterns in the overall text.\n",
        "                The output needs to sections, clearly delineated: 'Background', and 'Provision'\n",
        "                Here is an example of what need for summary output:\n",
        "                Background:\n",
        "Practice Expense (PE) is the portion of resources used in furnishing a service that reflects the general categories of physician and practitioner expenses, such as office rent and personnel wages, but excluding malpractice (MP) expenses, as specified in section 1848(c)(1)(B) of the Act. PE RVUs are developed by considering the direct and indirect practice resources involved in furnishing each service. Direct expense categories include clinical labor, medical supplies, and medical equipment and are determined by adding the costs of the direct resources involved with furnishing that service. Indirect expenses include administrative labor, office expense, and all other expenses and are calculated using Physician Practice Expense Information Survey (PPIS) data that demonstrated the practice expenses incurred per hour worked. If a procedure can be done in a physician office and a facility setting, there are two PE RVUs: facility and non-facility. The CY 2010 PFS final rule, as well as the Calculations of PE RVUs under Methodology for Selected Codes file provides more detailed descriptions of the PE RVU methodology.\n",
        "The Medicare Economic Index (MEI) is an index that measures changes in the market price of inputs used to furnish physician services. Essentially, it is a measure that takes into account inflation of costs. In CY 2023, CMS finalized to rebase and revise the MEI to reflect current market conditions, but it was not used in rate setting.\n",
        "\n",
        "Provision:\n",
        "CMS is proposing to NOT incorporate the finalized 2017-based MEI in PFS rate setting for CY 2024. This is due to AMAs intention to collect practice cost data from physician practices in the near future which could be used to derive cost share weights for the MEI and RVU shares, as well as the methodological and data source changes that could significantly impact PFS payments.\n",
        "                \"\"\"\n",
        "    return get_gpt4_summary(row['text'], prompt)\n",
        "\n",
        "# Apply summarization function to each row\n",
        "TEST_merged_df_Topic_text_combined['Topic Summary'] = TEST_merged_df_Topic_text_combined.apply(summarize_topics, axis=1)\n",
        "\n",
        "# Create final DataFrame\n",
        "Final_Topic_Summary_df = TEST_merged_df_Topic_text_combined[['InsightsAI_Topic', 'Topic Summary', 'text']]\n",
        "\n",
        "def generate_html_output(df):\n",
        "    html_content = '''\n",
        "    <style>\n",
        "        body {\n",
        "            font-family: \"Arial\", sans-serif;\n",
        "        }\n",
        "        .summary-container {\n",
        "            margin: 20px;\n",
        "            padding: 15px;\n",
        "            border-radius: 8px;\n",
        "            background-color: #f9f9f9;\n",
        "            box-shadow: 0 2px 4px rgba(0,0,0,0.1);\n",
        "        }\n",
        "        .topic-title {\n",
        "            color: #333;\n",
        "            font-size: 18px;\n",
        "        }\n",
        "        .summary-text {\n",
        "            color: #555;\n",
        "            font-size: 14px;\n",
        "            margin-top: 5px;\n",
        "        }\n",
        "    </style>\n",
        "    <div class=\"summary-container\">\n",
        "        <h2 style=\"color: #4B0082;\">Summary Overview</h2>'''\n",
        "\n",
        "    for _, row in df.iterrows():\n",
        "        html_content += f'''\n",
        "            <div>\n",
        "                <h3 class=\"topic-title\">Topic: {row[\"InsightsAI_Topic\"]}</h3>\n",
        "                <p class=\"summary-text\"><strong>Summary:</strong> {row[\"Topic Summary\"]}</p>\n",
        "            </div>'''\n",
        "\n",
        "    html_content += '</div>'\n",
        "    return HTML(html_content)\n",
        "\n",
        "\n",
        "# Call the function to display HTML output\n",
        "html_output = generate_html_output(Final_Topic_Summary_df.head(1))\n",
        "html_output\n",
        "# Display the final DataFrame\n",
        "#Final_Topic_Summary_df.head()\n",
        "\n",
        "\n",
        "\n",
        "###########################################################################################################################\n",
        "# write out html file\n",
        "with open('final_topic_summary.html', 'w', encoding='utf-8') as f:\n",
        "    f.write(str(html_output))  # Convert HTML object to string before writing\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "IxKvHkKVGjMX"
      },
      "outputs": [],
      "source": []
    }
  ],
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyPEDiQbYOLkQ+boEf/PRty9",
      "include_colab_link": true
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}